Unspecified lump in breast

N14_LUMPNASBREAST

breast disease: A disease involving the breast.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions None	293218
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N63 Hospital discharge: ICD-9 — 6117B Cause of death: ICD-10 — N63 Cause of death: ICD-9 — 6117B 2 out of 7 registries used, show all original rules.	6818
4. Check minimum number of events None	6818
5. Include endpoints None	6818
6. Filter based on genotype QC (FinnGen only)	6566

Control definitions (FinnGen only)

Control exclude: N14_BREAST

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N60-N64
Name in latin: Nodulus mammae non specificatus

NAME	N14_LUMPNASBREAST
CONTROL_EXCLUDE	N14_BREAST
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N63
HD_ICD_9	6117B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N63
COD_ICD_9	6117B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Unspecified lump in breast based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	47503	47503	-
Only index persons	44685	44685	-
Unadjusted period prevalence (%)
Whole population	1.36	1.36	-
Only index persons	1.64	1.64	-
Median age at first event (years)
Whole population	-	50.39	-
Only index persons	-	50.01	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6566	6566	-
Unadjusted period prevalence (%)	2.33	2.33	-
Median age at first event (years)	49.39	49.39	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6818: Matched controls
68180

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.7

308.3

510

812

D24

ICD-10 Finland

Benign neoplasm of breast

17.7

307.7

867

556

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

+∞

307.7

578

HAC20

NOMESCO Finland

Total mastectomy

5.1

307.7

852

1845

N62

ICD-10 Finland

Hypertrophy of breast

91.6

307.7

389

HAB99

NOMESCO Finland

Other partial excision of mammary gland

14.0

307.7

995

823

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

70.0

307.7

282

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

10.1

307.7

427

448

9702

FHL

Breast exploration and possible tumor removal

21.3

307.7

503

254

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.7

307.7

1490

3205

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

5.0

307.7

1005

2270

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

4.3

307.7

1129

2980

N60.2

ICD-10 Finland

Fibroadenosis of breast

54.3

307.7

246

HAA10

NOMESCO Finland

Biopsy of mammary gland

21.9

307.7

348

167

115

Kela drug reimbursment

Breast cancer

4.0

307.7

1581

4822

N64.9

ICD-10 Finland

Disorder of breast, unspecified

30.8

307.7

373

128

HA1AA

NOMESCO Finland

X-ray mammography

4.2

307.7

1440

4075

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

60.5

307.7

1916

438

N63

ICD-10 Finland

Unspecified lump in breast

427.3

307.7

6300

1887

HAB40

NOMESCO Finland

Wedge excision of mammary gland

4.7

307.7

1071

2609

N61

ICD-10 Finland

Inflammatory disorders of breast

8.9

296.2

376

442

N64.5

ICD-10 Finland

Other signs and symptoms in breast

8.5

294.4

391

486

PJA12

NOMESCO Finland

Sentinel node biopsy

3.4

293.2

1262

4300

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

6.6

292.2

488

784

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

4.6

285.1

726

1709

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

6.7

276.5

458

729

HAB20

NOMESCO Finland

Excision of lactiferous duct

132.5

258.0

130

C50.99

ICD-10 Finland

Breast, unspecified

5.2

257.1

564

1170

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

6.0

254.0

469

831

L02BA01

ATC

tamoxifen; oral

4.1

242.9

735

1966

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

4.3

228.1

643

1630

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

4.8

216.5

517

1149

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

6.5

213.9

357

571

N60.0

ICD-10 Finland

Solitary cyst of breast

26.5

207.8

143

THA00

NOMESCO Finland

Needle biopsy of mamilla

63.2

202.8

112

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

5.8

185.3

349

628

L02BG04

ATC

letrozole; oral

2.9

181.1

997

3845

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

7.0

181.0

283

422

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

5.8

163.0

303

538

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

6.7

160.2

260

403

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

8.1

147.4

199

251

ZXA05

NOMESCO Finland

Left side

2.0

138.1

1950

11228

TQW20

NOMESCO Finland

Tatoe

6.9

138.0

216

322

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

133.2

2949

19692

HAE99

NOMESCO Finland

Other reconstruction of breast

8.5

132.7

173

209

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

5.2

131.8

275

542

9703

FHL

Breast resection

8.5

127.3

165

198

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

37.1

124.1

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

4.9

120.9

272

572

N64.8

ICD-10 Finland

Other specified disorders of breast

14.2

119.4

109

N60.8

ICD-10 Finland

Other benign mammary dysplasias

307.8

118.6

120

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

4.5

117.8

295

677

HA5CB

NOMESCO Finland

Galactography

55.5

116.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

4.9

116.4

265

563

ZXA00

NOMESCO Finland

Right side

1.9

115.8

2002

12223

C50

ICD-10 Finland

Malignant neoplasm of breast

3.7

114.6

384

1090

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

112.9

1691

9831

ZXD20

NOMESCO Finland

Day surgery

2.2

111.8

1124

5641

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

111.5

1922

11699

H02AB02

ATC

dexamethasone; systemic

2.2

109.5

1026

5002

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

4.7

109.2

259

569

ZXE00

NOMESCO Finland

One hour or less

1.7

103.0

2872

20081

L03AA13

ATC

pegfilgrastim; parenteral

2.9

102.2

502

1798

L02BG03

ATC

anastrozole; oral

4.3

100.8

271

657

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

4.2

96.8

262

638

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

7.1

94.7

144

208

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

12.2

94.2

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

4.3

93.8

251

606

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

3.6

93.4

323

935

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

3.8

91.6

283

759

HAD99

NOMESCO Finland

Other plastic operation on breast

8.4

89.9

117

141

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

2.6

88.9

573

2356

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

9.7

88.1

103

108

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

7.8

87.4

121

157

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

5.2

87.4

181

354

ZZR10

NOMESCO Finland

Flap of skin and muscle

6.6

87.4

142

220

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

86.2

2543

17812

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

9.2

83.4

101

111

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

8.7

83.0

105

122

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.2

81.3

139

227

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

4.0

78.9

233

605

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

9.0

77.0

107

X19

ICPC

Breast lump/mass female

3.8

76.3

234

624

A04AA02

ATC

granisetron; systemic, transdermal

2.4

75.3

550

2392

Z71.8

ICD-10 Finland

Other specified counselling

1.6

74.7

2274

15914

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.4

74.6

526

2251

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

9.0

74.3

104

Z3231

NOMESCO Finland

Registered nurse

1.7

71.4

1812

12072

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

8.0

70.2

120

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

12.6

67.5

X76

ICPC

Malignant neoplasm breast female

3.3

67.4

262

816

R4110

NOMESCO Finland

Physiotherapy

1.6

66.5

1911

13102

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

8.0

66.4

114

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

6.3

66.2

112

181

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

65.5

1719

11511

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

91.0

65.0

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

7.1

64.7

138

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

3.8

64.6

204

555

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

4.5

64.0

157

354

X21

ICPC

Breast sympt/compl female other

3.3

62.6

237

726

N60.4

ICD-10 Finland

Mammary duct ectasia

164.0

62.0

L02BG06

ATC

exemestane; oral

3.3

61.8

236

727

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.0

61.7

288

999

N64.4

ICD-10 Finland

Mastodynia

2.8

61.4

324

1201

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.4

59.9

223

676

Z31.5

ICD-10 Finland

Genetic counselling

2.3

58.8

479

2179

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

58.6

2678

20290

D05.0

ICD-10 Finland

Lobular carcinoma in situ

11.7

57.6

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

5.8

57.0

104

181

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

56.2

443

1986

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

7.5

53.8

104

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

6.8

53.7

125

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

3.9

52.7

159

419

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

2.2

52.3

453

2112

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

6.3

52.1

142

HA1AE, ,

SPAT

2.6

51.1

299

1168

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

5.8

48.8

155

Z3226

NOMESCO Finland

Physiotherapist

1.6

48.6

1225

8037

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

2.5

48.1

301

1215

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

2.4

47.9

355

1548

Z2221

NOMESCO Finland

Medical doctor

1.5

47.9

1878

13635

HAD20

NOMESCO Finland

Liposuction of breast

12.9

47.7

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

6.7

47.0

111

61000

ICD-8 Finland

Chronic cystic disease of breast, Fibroadenomatosis mammae

+∞

46.9

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

6.0

45.8

137

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

45.5

2566

19987

L02BA03

ATC

fulvestrant; parenteral

4.8

45.5

102

214

HAC25

NOMESCO Finland

Radical mastectomy

6.2

44.9

123

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.9

44.4

611

3368

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

44.2

1950

14459

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

7.6

44.1

192

Kela drug reimbursment

Fulvestrant

5.2

42.9

171

6101A

ICD-9 Finland

Benign mammary dysplasias, Diffuse cystic mastopathy

+∞

42.7

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

7.0

42.3

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.1

42.3

443

2221

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

4.7

41.9

205

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.4

40.6

147

438

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

4.1

40.5

110

269

A04AA55

ATC

palonosetron, combinations; systemic

2.2

40.5

341

1570

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

3.1

38.7

160

518

RD211, ,

NOMESCO Finland

2.2

36.9

313

1444

J01DB01

ATC

cefalexin; oral

1.5

36.8

5482

49947

NK6AN

NOMESCO Finland

Total body bone isotope imaging

3.0

36.7

166

566

61099

ICD-8 Finland

Chronic cystic disease of breast, Unspecified

+∞

35.4

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

2.5

35.4

231

951

HAD40

NOMESCO Finland

Mastopexy

5.1

35.2

147

ZX120

NOMESCO Finland

Intravenous

1.8

35.2

601

3533

Z00.0

ICD-10 Finland

General medical examination

1.5

35.1

1190

8297

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

9.6

35.0

N60.3

ICD-10 Finland

Fibrosclerosis of breast

180.9

34.8

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

7.5

34.3

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

4.5

34.2

186

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

7.6

33.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

33.4

676

4162

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

8.3

32.9

WZC30

NOMESCO Finland

Teaching

1.6

32.7

947

6370

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

5.2

32.3

128

HAD00

NOMESCO Finland

Augmentation mammoplasty

11.4

31.8

QBJ00

NOMESCO Finland

Liposuction in trunk

5.1

31.5

131

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

4.7

31.2

155

X26

ICPC

Fear of breast cancer female

4.1

30.9

206

1501

Kela drug reimbursment

Palbociclib

4.3

30.4

187

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

7.9

30.2

A04AD12

ATC

aprepitant; systemic

2.5

30.1

187

752

A02BC02

ATC

pantoprazole; systemic

1.4

29.9

4515

40258

394

Kela drug reimbursment

Palbociclib

4.3

29.2

172

HAA00

NOMESCO Finland

Incision of mammary gland

56.9

29.1

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

4.2

28.8

178

J02AC01

ATC

fluconazole; systemic

1.3

28.2

3220

27444

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

3.9

28.1

212

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

6.0

28.0

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

2.3

28.0

221

991

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

27.2

481

2849

N02BE01

ATC

paracetamol; systemic, rectal

1.5

27.2

6015

56626

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

4.0

27.1

191

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

26.9

2259

18376

JN4BD

NOMESCO Finland

Extensive body CT

1.6

26.1

577

3627

WX402

NOMESCO Finland

General anaesthesia

1.4

26.1

1286

9584

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

25.3

426

2488

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

5.0

25.3

109

9719

FHL

Other measure in this category

9.4

25.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

25.1

372

2093

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

6.1

25.0

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.0

25.0

296

1549

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

24.9

492

3003

N02AX02

ATC

tramadol; systemic, rectal

1.3

24.9

2552

21294

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

3.9

24.6

182

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

4.1

24.6

169

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

4.6

24.5

124

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.9

24.4

112

386

A02BC05

ATC

esomeprazole; systemic

1.3

24.1

2676

22543

Z00.8

ICD-10 Finland

Other general examinations

1.7

23.9

471

2872

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

3.8

23.9

195

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.4

23.8

170

731

HA1RA, ,

SPAT

1.8

23.6

385

2227

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.0

23.6

244

1216

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

23.4

386

2240

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

23.4

1431

11039

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

23.3

302

1629

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

23.0

1088

8035

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

22.9

1648

13031

HA1SA

NOMESCO Finland

Expansion mammography

4.4

22.9

131

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

19.0

22.5

J01MA02

ATC

ciprofloxacin; systemic

1.3

22.3

2187

18063

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

22.0

4559

41449

J01FF01

ATC

clindamycin; systemic

1.3

22.0

1605

12708

A04AA01

ATC

ondansetron; systemic, rectal

1.6

21.9

542

3502

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

21.8

1757

14110

HA3RT

NOMESCO Finland

Coagulation of mammary neoplasm under radiological guidance

38.7

21.7

Z51.0

ICD-10 Finland

Radiotherapy session

3.1

21.6

294

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

4.2

21.6

133

ZXA10

NOMESCO Finland

Bilateral

1.4

21.4

1097

8201

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

3.4

21.4

230

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

4.2

21.1

135

P01AB01

ATC

metronidazole; oral, rectal

1.3

21.0

2790

23919

R07.3

ICD-10 Finland

Other chest pain

1.5

20.9

604

4042

PJA10

NOMESCO Finland

Exploration of lymph nodes

3.2

20.6

256

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

20.5

540

3536

S04

ICPC

Lump/swelling localized

1.5

20.2

635

4324

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

3.3

20.1

229

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

6.8

19.9

N06AX16

ATC

venlafaxine; oral

1.4

19.4

931

6876

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

19.3

684

4771

2170A

ICD-9 Finland

Benign neoplasm of breast[NEOPLASMA BENIGNUM MAMMAE]

3.6

19.3

172

M79.6

ICD-10 Finland

Pain in limb

1.3

19.2

2760

23807

M05BX04

ATC

denosumab; parenteral

1.6

19.2

427

2686

L01EF01

ATC

palbociclib; oral

4.3

19.2

115

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

4.9

19.1

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

19.1

2289

19308

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

18.8

511

3369

Z01.7

ICD-10 Finland

Laboratory examination

1.4

18.6

884

6516

J01DA01

ATC

[U] cefalexin

1.3

18.6

3958

35694

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

18.5

591

4036

HAF00

NOMESCO Finland

Excision of local recurrence of breast cancer

15.1

18.4

9706

FHL

Ablation mammae, includes axillary exploration

6.4

18.3

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

18.3

2221

18739

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

18.2

3131

27523

K30

ICD-10 Finland

Functional dyspepsia

1.4

18.1

740

5303

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

17.9

829

6080

L01XE33

ATC

[U] palbociclib

4.1

17.7

114

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.7

17.6

355

2177

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

17.6

505

3371

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

3.0

17.6

249

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

17.5

1202

9386

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

17.5

2698

23382

B29

ICPC

Lymph/immune mech sympt/complt other

4.5

17.5

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

17.4

234

1277

R42

ICD-10 Finland

Dizziness and giddiness

1.3

17.1

1410

11299

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

17.1

619

4334

Z50.1

ICD-10 Finland

Other physical therapy

1.7

17.1

320

1925

WF002

NOMESCO Finland

Radical radiotherapy

2.0

17.1

189

967

R53

ICD-10 Finland

Malaise and fatigue

1.3

17.0

1453

11698

J01FA10

ATC

azithromycin; systemic

1.2

16.8

3825

34552

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2.0

16.8

187

959

S18

ICPC

Laceration/cut

1.2

16.7

2625

22763

R06AE07

ATC

cetirizine; oral

1.2

16.7

2995

26356

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

5.3

16.5

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

4.1

16.5

107

B01AB05

ATC

enoxaparin; parenteral

1.3

16.5

1924

16114

L03AA02

ATC

filgrastim; parenteral

2.0

16.4

180

918

QBA00

NOMESCO Finland

Puncture of skin of trunk

4.5

16.3

J01MA12

ATC

levofloxacin; systemic

1.4

16.3

931

7063

R51.80

ICD-10 Finland

Headache

1.4

16.2

982

7522

R05

ICD-10 Finland

Cough

1.3

16.1

1318

10545

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.3

16.0

115

498

R2110

NOMESCO Finland

Giving the first information

1.5

15.9

467

3133

A02BA02

ATC

ranitidine; systemic

1.3

15.8

1111

8696

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

2.8

15.7

282

KMAK, ,

NOMESCO Finland

1.2

15.7

3218

28656

N64.1

ICD-10 Finland

Fat necrosis of breast

+∞

15.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

15.6

1585

13032

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

2.6

15.6

340

G44.2

ICD-10 Finland

Tension-type headache

1.4

15.6

921

7022

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

5.3

15.6

J01DA09

ATC

[U] cefadroxil

1.3

15.4

1592

13114

R03AC02

ATC

salbutamol; inhalant

1.2

15.3

3575

32233

N05CF01

ATC

zopiclone; oral

1.3

15.3

1949

16463

TQB05

NOMESCO Finland

Puncture of skin of trunk

2.8

15.2

270

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

1.9

15.2

182

957

J01AA02

ATC

doxycycline; systemic

1.3

15.2

5119

47999

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

4.5

15.1

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

15.1

335

2106

N05BA01

ATC

diazepam; systemic, rectal

1.4

15.0

748

5546

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

14.9

610

4368

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

5.2

14.8

X58

ICD-10 Finland

Exposure to other specified factors

1.4

14.7

710

5234

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

14.7

5986

57361

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.2

14.7

121

555

M03BX02

ATC

tizanidine; oral

1.2

14.6

4041

36989

N05CB02

ATC

barbiturates in combination with other drugs

1.9

14.6

185

992

61001

ICD-8 Finland

Chronic cystic disease of breast, Cysta (cystis) mammae

+∞

14.6

R01AD09

ATC

mometasone; nasal

1.2

14.5

2974

26402

-1, ,

NOMESCO Finland

1.3

14.5

1930

16363

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

2.5

14.5

341

N03AX16

ATC

[U] pregabalin

1.3

14.3

1412

11548

J01FA09

ATC

clarithromycin; systemic

1.2

14.3

1984

16890

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

14.3

1785

15018

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1.8

14.3

206

1151

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.3

14.2

101

435

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

14.1

399

2654

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

3.9

14.1

102

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

14.1

789

5960

R52.9

ICD-10 Finland

Pain, unspecified

1.4

14.0

585

4204

C07AA05

ATC

propranolol; systemic

1.3

14.0

1281

10378

A02BC01

ATC

omeprazole; systemic

1.3

13.8

1614

13467

WX199

NOMESCO Finland

Other local analgesia

1.9

13.7

176

950

PUHSE, ,

NOMESCO Finland

6.5

13.6

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

1.9

13.6

157

818

61199

ICD-8 Finland

Other diseases of breast, Other

+∞

13.5

6110A

ICD-9 Finland

Other disorders of breast, Inflammatory disease of breast

+∞

13.5

61008

ICD-8 Finland

Chronic cystic disease of breast, Alia definita

+∞

13.5

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

3.3

13.5

148

Z01.2

ICD-10 Finland

Dental examination

1.2

13.5

2860

25410

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.8

13.5

189

1048

XX1AD

NOMESCO Finland

Other CT-examination

3.3

13.4

149

L02AE03

ATC

goserelin; implant

2.6

13.3

279

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.8

13.2

203

1157

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

13.1

324

2091

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

13.1

414

2819

M79.1

ICD-10 Finland

Myalgia

1.3

13.0

892

6940

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

13.0

727

5485

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

13.0

1350

11094

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

12.9

318

2050

R01AD08

ATC

fluticasone; nasal

1.2

12.9

1786

15172

A79

ICPC

Malignancy NOS

2.4

12.9

361

WX002

NOMESCO Finland

Sedation and analgesia

1.3

12.9

1101

8833

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

12.8

250

1522

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

3.3

12.8

143

L01CA04

ATC

vinorelbine; systemic

2.8

12.8

222

1CD02, ,

NOMESCO Finland

2.5

12.7

297

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

10.5

12.7

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

12.6

1227

10003

L01BC06

ATC

capecitabine; oral

1.7

12.6

212

1242

R06.0

ICD-10 Finland

Dyspnoea

1.3

12.5

1515

12670

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

12.5

1084

8706

6102A

ICD-9 Finland

Benign mammary dysplasias, Fibroadenosis of breast

+∞

12.5

J05AB01

ATC

aciclovir; systemic

1.3

12.5

1398

11587

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

12.4

1306

10746

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

12.4

372

2507

N05CF02

ATC

zolpidem; oral

1.3

12.4

1091

8782

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.3

12.4

418

D01

ICPC

Abdominal pain/cramps general

1.4

12.3

708

5369

R00.2

ICD-10 Finland

Palpitations

1.4

12.1

497

3559

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

3.1

12.1

159

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

12.0

1094

8837

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

12.0

498

3575

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

11.0

12.0

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

12.0

825

6421

ZX112

NOMESCO Finland

Subcutaneous

2.1

12.0

117

575

UJD02

NOMESCO Finland

Gastroscopy

1.6

11.8

248

1541

J02AC02

ATC

itraconazole; systemic

1.3

11.7

1129

9183

X18

ICPC

Breast pain female

2.0

11.7

116

573

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

3.6

11.7

107

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

11.6

1358

11303

9020/3-C50.9

ICD-O-3

Phyllodes tumor, malignant of breast, NOS

65.1

11.6

N05BA04

ATC

oxazepam; oral

1.2

11.5

1605

13616

Q83.1

ICD-10 Finland

Accessory breast

5.0

11.4

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

11.4

299

1957

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

3.3

11.3

124

X79

ICPC

Benign neoplasm breast female

11.8

11.3

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

11.3

691

5285

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

3.1

11.2

150

3030

Kela drug reimbursment

Abemaciclib

5.1

11.2

R4120

NOMESCO Finland

Occupational therapy

1.5

11.2

351

2387

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.5

11.2

327

2192

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

11.1

955

7658

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

11.1

1998

17387

R03DC03

ATC

montelukast; oral

1.3

11.0

1056

8580

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

11.0

959

7699

1515, ,

Kela drug reimbursment

5.0

11.0

A03CA02

ATC

clidinium and psycholeptics; oral

1.5

10.9

324

2179

UJF32

NOMESCO Finland

Coloscopy

1.2

10.9

1451

12235

Z2446

NOMESCO Finland

Social worker

1.5

10.9

315

2107

N02AA05

ATC

oxycodone; systemic

1.3

10.9

851

6735

N64.0

ICD-10 Finland

Fissure and fistula of nipple

43.4

10.9

N30.0

ICD-10 Finland

Acute cystitis

1.3

10.9

1162

9562

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

10.9

3142

28523

N06AX11

ATC

mirtazapine; oral

1.2

10.8

2078

18177

HAB30

NOMESCO Finland

Excision of mamilla or areola

15.5

10.8

RF210, ,

NOMESCO Finland

1.8

10.8

160

904

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

10.8

2921

26357

A60

ICPC

General and Unspecified, Result test/procedure

1.6

10.8

242

1530

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.7

10.7

194

1161

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

10.7

416

2952

WF049

NOMESCO Finland

Radiotherapy of metastasis

1.8

10.7

155

871

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

5.0

10.5

H57.1

ICD-10 Finland

Ocular pain

1.6

10.5

217

1344

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

4.3

10.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

10.5

1638

14039

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

10.5

281

1851

R5110, ,

SPAT

1.5

10.4

375

2623

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

10.4

1901

16540

R50.9

ICD-10 Finland

Fever, unspecified

1.3

10.4

717

5580

N06AB04

ATC

citalopram; systemic

1.2

10.4

1281

10713

FM1FN

NOMESCO Finland

Heart function isotope examination

2.8

10.3

185

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

10.3

593

4491

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

10.3

971

7866

N05CD07

ATC

temazepam; oral

1.4

10.3

588

4448

N64

ICD-10 Finland

Other disorders of breast

4.2

10.3

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

10.3

346

2387

J01MA14

ATC

moxifloxacin; systemic

1.4

10.3

442

3193

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

3.4

10.3

102

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

10.3

342

2357

R83

ICPC

Respiratory infection other

1.2

10.2

1487

12646

M01AB05

ATC

diclofenac; systemic, rectal

1.2

10.1

4131

38515

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.8

10.1

159

916

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

10.0

412

2956

R52.2

ICD-10 Finland

Other chronic pain

1.6

9.9

210

1309

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

9.9

945

7670

M54.5

ICD-10 Finland

Low back pain

1.2

9.9

2196

19435

N03AX12

ATC

[U] gabapentin; oral

1.3

9.8

938

7611

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

9.8

1048

8616

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

9.8

202

1251

J01CA08

ATC

pivmecillinam; oral

1.2

9.8

3457

31802

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.0

9.7

107

550

U07

ICPC

Urine symptom/complaint other

1.4

9.7

419

3029

A02BC03

ATC

lansoprazole; oral

1.2

9.7

1681

14538

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

9.7

500

3726

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

2.1

9.7

429

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

9.6

531

3997

R06AX27

ATC

desloratadine; oral

1.2

9.6

1805

15732

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

9.5

585

4478

S16

ICPC

Bruise/contusion

1.7

9.4

165

979

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

2.7

9.4

183

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

9.4

214

1357

A04AA03

ATC

tropisetron; systemic

3.7

9.4

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.5

9.4

292

1985

M25.5

ICD-10 Finland

Pain in joint

1.2

9.4

2026

17865

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

9.4

555

4224

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

9.3

3378

31085

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

4.4

9.3

M01AG02

ATC

tolfenamic acid; oral, rectal

1.2

9.3

1051

8694

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

9.3

1154

9645

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

9.3

419

3055

M01AE02

ATC

naproxen; oral, rectal

1.2

9.3

3531

32621

ZX100

NOMESCO Finland

Oral

2.3

9.2

306

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

9.2

273

1840

J01EA01

ATC

trimethoprim; systemic

1.2

9.2

1883

16526

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

9.2

1581

13656

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.5

9.1

276

1866

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.9

9.1

117

634

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.6

9.1

206

1306

N06AX21

ATC

duloxetine; oral

1.3

9.1

714

5652

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

9.1

2429

21801

A04

ICPC

Weakness/tiredness general

1.3

9.0

814

6555

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

9.0

259

1732

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.3

9.0

303

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

9.0

723

5740

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

8.9

244

1615

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

0.7

8.9

221

3333

C07AB07

ATC

bisoprolol; oral

1.2

8.8

2577

23276

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

8.8

4526

42728

ZX090

NOMESCO Finland

Other technic of radiotherapy

1.7

8.8

143

832

D11

ICPC

Diarrhoea

1.3

8.8

664

5229

J01FA06

ATC

roxithromycin; oral

1.2

8.8

2459

22135

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

8.7

241

1599

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

3.3

8.7

E0000UV, ,

ATC

1.2

8.7

2555

23077

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

8.7

1444

12417

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.0

8.7

440

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.0

8.7

454

WYA00, ,

SPAT

2.1

8.7

367

J01CF02

ATC

cloxacillin; systemic

1.9

8.7

517

R60.0

ICD-10 Finland

Localized oedema

1.3

8.7

659

5195

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

8.7

409

3005

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.5

8.6

226

1483

D06BB03

ATC

aciclovir; topical

1.5

8.6

291

2013

XF404

NOMESCO Finland

Ambulatory ECG

1.4

8.6

412

3033

M54.2

ICD-10 Finland

Cervicalgia

1.4

8.6

435

3231

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

3.9

8.6

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

8.6

377

2736

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.0

8.6

477

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

8.6

505

U02

ICPC

Urinary frequency/urgency

1.2

8.6

954

7876

C01CA24

ATC

epinephrine; parenteral

1.4

8.5

354

2544

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.4

8.5

382

2783

R74

ICPC

Upper respiratory infection acute

1.2

8.5

1933

17095

WZC30, ,

SPAT

1.5

8.5

281

1937

A06AD11

ATC

lactulose; oral

1.3

8.4

681

5411

R06AX22

ATC

ebastine; oral

1.2

8.4

1079

9042

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

8.4

444

3321

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.5

8.4

264

1801

A10AA01, ,

ATC

1.8

8.4

113

623

M02AA07

ATC

piroxicam; topical

1.2

8.4

2173

19423

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

8.4

464

3498

6111A

ICD-9 Finland

Other disorders of breast, Hypertrophy of breast

+∞

8.3

61009, ,

ICD-8 Finland

+∞

8.3

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

8.3

946

7824

N05BA12

ATC

alprazolam; oral

1.3

8.3

568

4412

Z29.8

ICD-10 Finland

Other specified prophylactic measures

1.7

8.3

153

922

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

8.3

947

7836

J01DA08

ATC

[U] cefaclor

1.3

8.2

573

4462

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

2.2

8.2

302

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

3.8

8.2

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

2.0

8.2

402

R03BA05

ATC

fluticasone; inhalant

1.2

8.2

1052

8814

UKC02

NOMESCO Finland

Cystoscopy

1.3

8.2

533

4112

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

8.2

1067

8956

L01

ICPC

Neck symptom/complaint

1.2

8.2

946

7841

J01MA06

ATC

norfloxacin; oral

1.3

8.1

833

6810

R4190

NOMESCO Finland

Nutritional therapy

1.6

8.1

171

1067

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.8

8.1

105

572

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.8

8.1

135

5702

FHL

Local lymph node removal (eg armpit, groin)

3.1

8.1

103

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.6

8.1

169

J45.9

ICD-10 Finland

Asthma, unspecified

1.2

8.1

1098

9254

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.0

8.1

425

ZYC03

NOMESCO Finland

Remote contact, text-based

2.7

8.0

147

H3603, E103,

ICD-10 Finland

2.6

8.0

170

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

8.0

710

5709

U13

ICPC

Bladder symptom/complaint other

1.6

8.0

168

1049

1XC03, ,

NOMESCO Finland

2.9

7.9

120

1514, ,

Kela drug reimbursment

7.2

7.9

3002

Kela drug reimbursment

Ribociclib

7.2

7.9

D19

ICPC

Teeth/gum symptom/complaint

1.2

7.9

1646

14427

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

2.3

7.9

262

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.4

7.9

399

2963

D01AE16

ATC

amorolfine; topical

1.3

7.9

627

4969

N80.9

ICD-10 Finland

Endometriosis, unspecified

1.8

7.9

106

584

XCH00

NOMESCO Finland

Eye pressure measurement

1.5

7.9

237

1604

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

7.8

509

3926

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

3.6

7.8

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.4

7.8

220

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

3.2

7.8

C50.09

ICD-10 Finland

Malignant tumor of nipple and areola, other or undeterminated histology

6.9

7.8

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.7

7.7

125

728

R06AX13

ATC

loratadine; oral

1.2

7.7

907

7528

H02AB07

ATC

prednisone; oral

1.3

7.7

762

6203

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.5

7.7

215

1433

R01AD58

ATC

fluticasone, combinations; nasal

1.2

7.7

1472

12810

M01AH02

ATC

rofecoxib; oral

1.3

7.7

705

5690

N06AB06

ATC

sertraline; oral

1.3

7.6

624

4967

N06AB10

ATC

escitalopram; oral

1.2

7.6

1185

10119

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

7.6

414

3115

R01AD05

ATC

budesonide; nasal

1.3

7.6

429

3246

L01EF02

ATC

ribociclib; oral

7.1

7.5

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

7.4

470

3614

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

2.9

7.4

114

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.4

7.4

195

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.3

7.4

599

4761

J01DA06

ATC

[U] cefuroxime

1.2

7.4

810

6672

XKD00

NOMESCO Finland

Uroflowmetry

1.5

7.4

226

1536

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

7.3

332

2424

HMAK, ,

NOMESCO Finland

1.3

7.3

632

5061

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.0

7.3

344

HAC30

NOMESCO Finland

Excision of supernumerary mammary gland or mamilla

8.3

7.3

R1250

NOMESCO Finland

Evaluation of functional capability

1.8

7.3

111

636

6118X

ICD-9 Finland

Other disorders of breast, Other specified disorders of breast

+∞

7.3

HTEK, ,

NOMESCO Finland

6.8

7.3

WZC15, ,

NOMESCO Finland

2.7

7.3

132

A08

ICPC

Swelling

1.4

7.3

267

1880

CA1ME

NOMESCO Finland

Ultrasound oculometry

2.9

7.3

110

N76.0

ICD-10 Finland

Acute vaginitis

1.4

7.3

388

2910

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

2.0

7.3

359

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.3

7.2

537

4219

D02

ICPC

Abdominal pain epigastric

1.4

7.2

352

2601

D06

ICPC

Abdominal pain localized other

1.3

7.2

507

3954

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

7.2

2814

25853

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

1.9

7.2

450

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

1.6

7.2

140

858

RS222, ,

NOMESCO Finland

2.2

7.2

280

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.4

7.2

198

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

7.1

201

1342

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

7.1

680

5511

HAB10

NOMESCO Finland

Microductectomy of mammary gland

20.0

7.1

L12

ICPC

Hand/finger symptom/complaint

1.2

7.1

910

7616

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

2.1

7.1

301

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

7.1

712

5804

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

7.1

243

1688

D22

ICD-10 Finland

Melanocytic naevi

1.4

7.1

278

1980

M01AX17

ATC

nimesulide; oral

1.2

7.1

1363

11854

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.6

7.1

169

1088

S06.0

ICD-10 Finland

Concussion

1.3

7.1

517

4053

M01AH05

ATC

etoricoxib; oral

1.1

7.1

3894

36624

N30

ICD-10 Finland

Cystitis

1.3

7.1

541

4269

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1.5

7.0

202

1356

B02AA02

ATC

tranexamic acid; systemic

1.2

7.0

1041

8849

A46

ICD-10 Finland

Erysipelas

1.3

7.0

609

4887

121

Kela drug reimbursment

Severe hypofunction of sexual glands

1.7

6.9

123

736

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

6.9

443

3411

K07.60

ICD-10 Finland

Snapping jaw

1.4

6.9

307

2234

K58

ICD-10 Finland

Irritable bowel syndrome

1.6

6.9

147

921

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

1.3

6.9

411

3132

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

2.7

6.9

130

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.1

6.9

4129

39022

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2.0

6.9

380

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.6

6.9

171

1112

QDH05

NOMESCO Finland

Correction of deformity of toe nail

3.6

6.9

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

3.1

6.8

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

1.9

6.8

437

21799

ICD-8 Finland

Benign neoplasm of breast

2.2

6.8

260

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

1.7

6.8

122

733

8000/3-C50.9

ICD-O-3

Neoplasm, malignant of breast, NOS

10.9

6.8

DFF00

NOMESCO Finland

Pure tone audiometry

1.3

6.8

487

3811

H02AB06

ATC

prednisolone; systemic

1.1

6.8

2796

25755

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

1.6

6.8

147

927

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

6.7

1316

11458

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.7

6.7

109

637

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

6.7

590

4737

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

1.8

6.7

512

A29

ICPC

General symptom/complaint other

1.3

6.7

636

5153

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

7.2

6.7

J01MA01

ATC

ofloxacin; systemic

1.3

6.7

363

2730

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.5

6.7

208

1420

A07AA02

ATC

nystatin; oral

1.4

6.7

317

2336

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.7

6.6

108

632

G03DA02

ATC

medroxyprogesterone; systemic

1.2

6.6

687

5623

GD1AA, ,

SPAT

1.3

6.6

583

4684

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

6.6

270

1940

R01AD12

ATC

fluticasone furoate; nasal

1.2

6.6

1906

17115

A10AB04

ATC

insulin lispro; parenteral

1.6

6.6

130

801

J30.3

ICD-10 Finland

Other allergic rhinitis

1.5

6.6

186

1245

WF003

NOMESCO Finland

Adjuvant radiotherapy

1.5

6.6

184

1229

XF402

NOMESCO Finland

ECG with work load test

1.3

6.6

470

3677

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.2

6.6

842

7049

A10AA02, ,

ATC

1.6

6.6

126

771

L04

ICPC

Chest symptom/complaint

1.4

6.5

326

2421

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

2.4

6.5

182

EB1SA, ,

SPAT

1.4

6.5

285

2072

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

6.5

1649

14659

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.6

6.5

134

835

A11

ICPC

Chest pain NOS

1.3

6.5

400

3066

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

1.8

6.5

503

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.5

6.4

215

1488

2393A

ICD-9 Finland

Neoplasm of unspecified nature, Breast

2.6

6.4

135

N17

ICPC

Vertigo/dizziness

1.2

6.4

679

5568

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

6.4

313

2315

D69.2

ICD-10 Finland

Other nonthrombocytopenic purpura

3.5

6.4

D70.82

ICD-10 Finland

Drug-induced neutropenia

1.8

6.4

483

R20.2

ICD-10 Finland

Paraesthesia of skin

1.3

6.4

376

2862

U01

ICPC

Dysuria/painful urination

1.3

6.4

511

4055

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

6.3

1660

14786

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.3

6.3

386

2954

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

6.3

237

1677

ZX080

NOMESCO Finland

Image guided radiotherapy

1.7

6.3

117

710

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.2

6.3

223

G03DC02

ATC

norethisterone; oral

1.2

6.3

833

6995

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

5.5

6.3

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

1.9

6.3

407

ZZS55

NOMESCO Finland

Distension of tissue expander

9.2

6.3

D07AB08

ATC

desonide; topical

1.3

6.3

555

4460

L03AA14

ATC

lipegfilgrastim; parenteral

1.7

6.3

117

711

XLA10, ,

NOMESCO Finland

1.3

6.3

351

2654

K02.1

ICD-10 Finland

Caries of dentine

1.1

6.3

3453

32360

61101

ICD-8 Finland

Other diseases of breast, Abscessus mammae

+∞

6.2

R5120

NOMESCO Finland

Preparation of an aid

1.6

6.2

120

735

C05AA01

ATC

hydrocortisone; rectal, topical

1.4

6.2

248

1774

M01AH01

ATC

celecoxib; oral

1.2

6.2

1049

9011

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

1.6

6.2

144

923

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.2

6.2

218

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.2

6.2

621

5063

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

6.2

1067

9184

N05AH04

ATC

quetiapine; oral

1.2

6.2

879

7432

N80.0

ICD-10 Finland

Endometriosis of uterus

1.6

6.2

139

885

D27

ICPC

Fear of digestive disease other

2.4

6.2

162

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.2

6.2

717

5942

L28

ICPC

Limited function/disability (L)

1.2

6.2

937

7974

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

6.1

600

4879

2330A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Breast

7.7

6.1

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.2

6.1

839

7071

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.1

6.1

279

S21

ICPC

Skin texture symptom/complaint

1.2

6.1

736

6123

S21.0

ICD-10 Finland

Open wound of breast

8.6

6.0

XX9XW, ,

NOMESCO Finland

2.6

6.0

122

U71

ICPC

Cystitis/urinary infection other

1.3

6.0

455

3585

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

6.0

493

3924

R01AD11

ATC

triamcinolone; nasal

1.3

6.0

480

3808

WGA10

NOMESCO Finland

Measurement of pain intensity

10.0

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768793) Breast Pathology biopsy report

809

1824

4.90

307.65

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

495

1522

3.43

131.08

3.8

3.5

32.27

37.42

u/ml

0.43

486

1470

(40768804) Tissue Pathology biopsy report

3506

25774

1.74

106.22

2.3

2.0

—

(3002256) Pathology report gross observation

1258

7711

1.77

66.38

1.3

1.2

—

(4035726) Immunohistochemistry procedure

926

5326

1.85

59.79

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3667

30006

1.48

53.18

6.6

5.7

9.93

10.19

umol/l

1.19

3523

28295

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

377

1615

2.41

53.03

1.2

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5106

45279

1.51

45.06

8.5

7.2

75.62

77.39

u/l

2.10

4883

42512

(3013650) Neutrophils [#/volume] in Blood by Automated count

4014

34073

1.43

43.81

9.9

8.9

3.85

3.94

e9/l

1.37

3496

29739

(3015377) Calcium [Moles/volume] in Serum or Plasma

2648

20913

1.44

42.81

4.3

3.3

2.37

2.36

mmol/l

4.20

2404

18320

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

954

6107

1.65

41.12

3.8

3.7

7.68

26.63

ug/l

2.17

734

4789

(3044640) Blood type and Crossmatch panel - Blood

2338

18376

1.41

37.40

2.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

3368

28236

1.38

36.33

6.0

28.91

28.75

0.37

3194

26376

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

392

7203

0.52

35.37

5.5

6.4

—

(3006504) Eosinophils/100 leukocytes in Blood

3264

27312

1.37

35.16

5.9

2.73

2.81

1.21

3077

25406

(3018010) Neutrophils/100 leukocytes in Blood

3318

27844

1.37

35.07

5.9

5.7

56.69

56.77

0.14

3142

25968

(3019069) Monocytes/100 leukocytes in Blood

3278

27465

1.37

34.94

6.1

6.2

8.23

8.29

0.52

3099

25607

(3022096) Basophils/100 leukocytes in Blood

3158

26422

1.36

33.37

5.9

0.70

0.28

2971

24485

(3033658) Prothrombin time (PT) actual/Normal

1865

14326

1.42

33.08

3.7

3.5

96.08

95.09

0.98

1827

13893

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1420

10414

1.46

32.32

3.5

259.70

275.19

ng/l

0.09

946

7502

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5933

55334

1.56

32.00

14.7

12.0

82.49

81.44

ml/min/173m2

3.83

5039

45370

(3002582) Erythrocytes [#/volume] in Urine

2049

16367

1.36

27.64

3.2

3.0

38.48

62.56

e6/l

1.24

1533

12186

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1165

8462

1.45

27.35

2.8

2.7

5.01

4.47

e6/l

0.59

636

4298

(40758558) Short blood count panel - Blood

1918

15184

1.37

27.33

7.5

6.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

122

418

2.95

26.83

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3198

27413

1.31

26.07

2.5

2.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4923

44848

1.35

25.97

4.3

4.2

11.74

12.64

mm/h

5.25

4647

41569

(3018095) Leukocytes [#/volume] in Urine

2410

20011

1.32

24.15

3.9

3.5

94.39

109.09

e6/l

0.51

1636

13396

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3160

27264

1.30

23.63

2.4

2.3

79.43

3413.89

nmol/l

0.50

2933

24587

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1459

11293

1.37

23.34

3.2

2.9

2.47

2.46

mmol/l

1.38

1269

9880

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3358

29393

1.28

21.67

6.4

5.9

1.23

1.22

mmol/l

4.14

2974

24752

(3024561) Albumin [Mass/volume] in Serum or Plasma

2902

24962

1.28

21.45

4.4

4.3

36.09

35.78

g/l

2.53

2719

23092

(3030981) Hyaline casts [#/volume] in Urine by Automated count

415

2519

1.69

21.44

2.6

2.4

0.22

0.31

e6/l

1.45

401

2430

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6167

58825

1.51

21.28

15.1

13.0

19.74

20.80

mg/l

1.89

4837

46059

(3007164) IgA [Mass/volume] in Serum or Plasma

1532

12188

1.33

20.01

1.4

2.08

2.26

g/l

4.30

823

7210

(3013115) Eosinophils [#/volume] in Blood

3437

30348

1.27

19.94

5.9

0.18

e9/l

1.95

2991

26593

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

768

5449

1.46

19.94

2.4

2.3

33.28

37.19

u/l

1.11

647

4595

(3006315) Basophils [#/volume] in Blood

3332

29322

1.27

19.85

5.7

0.04

e9/l

0.41

2830

25268

(1617658) Protocol used for examination of sentinel lymph nodes

154

688

2.27

19.76

1.0

1.1

—

(3021589) Normoblasts [#/volume] in Blood

2982

25931

1.27

19.50

9.0

0.00

e9/l

0.70

2364

21096

(3019198) Lymphocytes [#/volume] in Blood

3406

30103

1.26

19.36

5.8

5.7

1.94

1.92

e9/l

0.17

2992

26604

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2243

18878

1.28

19.06

3.2

3.1

29.54

32.57

u/l

2.18

2138

17867

(3019550) Sodium [Moles/volume] in Serum or Plasma

6253

60033

1.50

18.56

16.0

14.4

139.64

139.69

mmol/l

0.77

6147

58463

(3001604) Monocytes [#/volume] in Blood

3311

29254

1.26

18.53

5.7

0.55

e9/l

0.90

2827

25258

(40768797) Stomach Pathology biopsy report

1107

8492

1.36

18.22

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1689

13840

1.29

17.39

2.2

2.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1634

13349

1.29

17.18

1.8

1.7

1.01

1.07

mg/l

0.48

1246

10139

(3013826) Glucose [Moles/volume] in Serum or Plasma

3632

32585

1.25

17.17

4.3

4.1

6.45

6.54

mmol/l

1.86

3436

30176

(3023103) Potassium [Moles/volume] in Serum or Plasma

6255

60189

1.48

16.93

16.2

14.5

3.92

3.93

mmol/l

2.82

6137

58489

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

150

2941

0.50

16.12

1.4

1.5

—

(40761535) Cells panel - Urine sediment

291

4631

0.61

14.90

3.2

3.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2721

23919

1.23

14.65

2.0

1.9

100.16

99.29

pmol/l

0.39

1233

11446

(40760892) CBC W Ordered Manual Differential panel - Blood

3088

27507

1.22

14.60

5.9

6.2

—

(3044889) 12 lead EKG panel

4370

40374

1.23

14.26

3.5

—

(36660697) Celiac disease serology panel - Serum

703

5213

1.39

14.07

1.1

1.2

—

(3042936) Bacteria identified in Isolate by Culture

938

7314

1.33

13.54

2.0

1.9

—

(3003338) MCHC [Mass/volume]

5270

49842

1.25

13.07

19.9

16.9

330.43

330.66

g/l

1.22

5242

49500

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

401

2716

1.51

13.05

1.1

17.53

1.73

u/ml

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

336

2194

1.56

12.94

2.1

1.9

—

(3048689) Calprotectin [Mass/mass] in Stool

991

7852

1.31

12.70

2.0

2.1

97.21

120.76

ug/g

2.08

763

6078

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1718

14562

1.24

12.60

1.3

1.50

1.59

u/ml

0.12

421

3952

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

589

4321

1.40

12.54

2.6

2.7

181.76

165.73

ng/l

0.46

530

3939

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6415

62409

1.47

12.51

11.8

10.2

23.22

23.75

u/l

1.08

6268

60160

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

116

3.55

12.50

1.2

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4324

40146

1.21

12.41

4.9

4.6

1944.26

2749.96

e6/l

0.43

467

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

843

6577

1.32

12.05

2.3

2.4

5.59

7.27

umol/l

4.35

717

5550

(3026782) Osmolality of Urine

1299

10722

1.26

11.97

2.9

2.8

494.88

501.57

mosm/kgh2o

0.55

1095

9111

(3022621) pH of Urine by Test strip

548

4006

1.40

11.91

3.3

3.1

—

(3030467) Casts [#/volume] in Urine by Automated count

1774

15186

1.23

11.70

3.1

2.9

0.29

0.42

e6/l

2.75

1291

11295

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

186

1078

1.75

11.49

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

186

1078

1.75

11.49

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3010

27192

1.19

11.08

2.9

2.8

92.58

95.77

ug/l

0.41

2846

25230

(3037467) Urinalysis macro (dipstick) panel - Urine

4404

41186

1.20

10.79

4.8

4.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

302

2013

1.52

10.64

2.0

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4116

38314

1.19

10.44

3.0

2.9

40.32

41.55

u/l

0.37

3873

35612

(3022145) Colonoscopy Study observation

830

6587

1.30

10.40

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

959

7752

1.28

10.40

1.9

2.0

29.25

29.38

0.34

943

7495

(3022217) INR in Platelet poor plasma by Coagulation assay

2722

24501

1.18

10.14

12.2

12.4

1.33

1.18

inr

0.48

901

7109

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1124

9306

1.25

9.91

2.7

2.5

1.15

1.74

e6/l

1.06

588

5108

(3020891) Body temperature

110

2009

0.54

9.52

6.2

4.4

—

(36304419) Bacteria [Presence] in Urine

1722

14973

1.20

9.31

3.1

2.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2922

26584

1.17

9.30

5.7

5.2

1.23

1.22

mmol/l

3.39

2705

24109

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

615

4785

1.31

8.90

2.9

3.1

79.67

81.13

ng/l

0.19

543

4050

(3018418) pH of Serum or Plasma

2029

17972

1.18

8.81

3.9

3.7

7.40

0.07

331

3387

(3002385) Erythrocyte distribution width [Ratio]

5352

51281

1.20

8.70

19.0

15.5

14.65

14.93

3.35

5289

50368

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

207

2.47

8.35

2.4

2.5

—

(3052851) Hemolysis interference index of Serum or Plasma

252

1723

1.48

7.94

2.9

3.0

—

(3023368) Bacteria identified in Blood by Culture

1531

13335

1.19

7.93

4.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5878

56964

1.23

7.85

5.7

5.4

2.14

2.09

mu/l

0.05

5566

52686

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1001

8380

1.23

7.85

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

650

5187

1.28

7.76

1.9

2.1

0.22

0.21

g/l

3.00

621

4845

(3000850) Epithelial cells [#/volume] in Urine

1326

11424

1.20

7.74

2.6

2.4

7.27

7.75

e6/l

0.40

1181

10132

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4116

38745

1.16

7.72

3.4

3.1

—

(40768443) Skin Pathology biopsy report

371

2736

1.38

7.70

1.3

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

340

2.07

7.55

1.4

1.5

69.93

72.01

umol/l

0.35

340

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

239

1640

1.47

7.42

1.9

2.0

97.89

95.59

1.02

228

1563

(3023323) Follitropin [Units/volume] in Serum or Plasma

488

3774

1.32

7.39

1.3

30.70

33.40

iu/l

0.99

422

3295

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2022

18114

1.17

7.35

2.5

2.4

58.47

58.93

u/l

0.09

1897

16569

(3009542) Hematocrit [Volume Fraction] of Blood

6601

65039

1.47

7.15

22.4

19.4

39.38

39.47

0.39

6250

61009

(3036489) Thrombin time

283

2026

1.41

7.03

1.7

1.9

20.69

21.27

1.41

243

1726

(3010813) Leukocytes [#/volume] in Blood

6609

65145

1.47

7.01

22.5

19.5

6.58

6.56

e9/l

0.04

6473

63313

(3026008) Bacteria identified in Urine by Culture

2298

20845

1.15

6.99

3.5

3.1

—

(3035941) MCH [Entitic mass]

6608

65139

1.47

6.95

22.4

19.4

30.20

30.13

2.69

6549

64238

(3024731) MCV [Entitic volume]

6608

65143

1.47

6.90

22.4

19.4

91.19

90.94

4.99

6549

64244

(3007461) Platelets [#/volume] in Blood

6605

65112

1.46

6.85

22.5

19.5

262.71

264.31

e9/l

1.28

6477

63471

(3026361) Erythrocytes [#/volume] in Blood

6608

65150

1.46

6.82

22.5

19.5

4.39

4.40

e12/l

1.47

6469

63337

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

522

4120

1.29

6.81

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

6609

65165

1.46

6.78

22.6

19.6

131.78

131.99

g/l

0.78

6553

64280

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

635

5154

1.26

6.59

3.9

3.7

90.08

55.41

u/ml

0.34

623

4962

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1038

8875

1.20

6.50

2.9

3.0

0.82

mmol/l

1.07

964

8267

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

269

1937

1.40

6.49

1.9

2.3

2.94

2.98

g/l

0.21

243

1722

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

2045

1.39

6.23

1.9

2.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

220

1542

1.44

6.18

2.2

2.3

177.90

187.22

0.93

208

1457

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

2048

1.38

6.17

1.9

2.3

7.39

7.56

g/l

1.01

254

1832

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

219

1536

1.44

6.14

1.8

2.3

0.00

0.02

g/l

1.17

199

1396

(3000494) Fungus identified in Specimen by Culture

806

6763

1.22

6.13

1.5

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

205

1421

1.46

6.12

1.2

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

279

2043

1.38

6.11

1.9

2.3

3.46

3.63

g/l

2.06

252

1827

(40761536) Microorganisms panel - Urine sediment

404

5153

0.77

5.98

4.5

4.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

597

7251

0.81

5.83

4.4

33.83

33.40

0.47

427

4853

(3007853) Bacteria identified in Skin by Aerobe culture

762

6413

1.21

5.62

1.8

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

259

1904

1.37

5.57

1.8

2.3

9.58

10.03

g/l

1.16

231

1671

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

293

2214

1.34

5.30

4.5

3.7

24.42

24.38

mmol/l

0.07

282

2172

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

662

5538

1.22

5.20

3.7

4.0

240.74

245.58

u/l

0.19

629

5208

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

230

1680

1.38

5.18

1.5

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

250

1851

1.36

5.17

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

249

1844

1.36

5.15

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

432

1.74

4.97

1.1

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

196

1405

1.41

4.95

1.9

2.3

0.00

g/l

-0.00

178

1290

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

245

1824

1.36

4.91

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

198

1428

1.40

4.83

1.9

2.3

0.00

g/l

0.66

179

1295

(3014111) Lactate [Moles/volume] in Serum or Plasma

516

4247

1.23

4.76

6.4

5.8

1.19

1.27

mmol/l

1.67

507

4148

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

395

3157

1.27

4.73

2.3

2.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1673

15191

1.13

4.65

1.5

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5163

50014

1.13

4.61

4.7

4.5

14.61

14.73

pmol/l

3.16

4847

45886

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

429

1.71

4.54

1.3

1.2

68.05

77.82

u/l

0.68

381

(3049717) Cytology report of Urine Cyto stain

181

1302

1.40

4.51

2.2

2.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1859

17022

1.13

4.49

2.0

2.1

144.70

168.42

u/l

0.70

1751

15862

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

233

1748

1.34

4.48

1.9

2.3

0.46

0.68

g/l

0.74

201

1494

(3025130) Human papilloma virus identified in Specimen

171

1220

1.41

4.47

1.6

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1636

14868

1.13

4.47

2.6

2.8

1079.14

1079.67

ng/l

0.00

1437

12629

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

561

4700

1.21

4.36

2.9

3.3

4.46

pmol/l

0.01

496

4173

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1269

11360

1.14

4.36

1.3

14.94

12.56

u/ml

0.51

492

4500

(3041096) Erythrocytes [Presence] in Urine by Automated

1730

15808

1.13

4.30

3.6

3.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.95

4.29

3.7

2.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

257

1971

1.32

4.27

3.2

3.3

1463.39

646.00

u/ml

0.57

211

1656

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

363

1.74

4.23

1.3

1.4

5.50

5.58

mmol/l

0.33

342

(3023420) DNA double strand Ab [Units/volume] in Serum

110

729

1.52

4.22

1.3

1.6

33.40

28.78

iu/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1327

11954

1.14

4.13

1.3

69.87

31.36

iu/ml

0.76

437

3992

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

377

3050

1.25

4.11

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1297

11681

1.14

4.05

1.7

1.5

—

(3000991) Gas panel - Venous blood

480

3993

1.22

4.03

7.6

7.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

250

1929

1.31

4.00

1.6

336.74

313.80

mu/l

0.39

222

1700

(3013139) Helicobacter pylori Ag [Presence] in Stool

539

4545

1.20

3.94

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

393

3217

1.24

3.87

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

262

2044

1.29

3.87

1.3

234.35

232.83

miu/ml

0.02

122

1005

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

420

1.65

3.83

1.3

1.2

20.05

22.22

u/l

0.13

360

(3027945) Reticulocytes/100 erythrocytes in Blood

635

5455

1.18

3.77

2.1

2.4

1.69

1.83

3.58

572

4794

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

312

2498

1.26

3.75

1.7

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

230

1772

1.31

3.74

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

482

4044

1.21

3.73

1.2

1.3

56.46

46.39

au/ml

0.42

226

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

212

1617

1.32

3.71

1.8

2.2

38.68

37.87

g/l

1.23

186

1394

(3037522) Nuclear Ab [Titer] in Serum

1006

8971

1.14

3.64

1.4

570.55

595.78

titre

0.15

220

2057

(3051611) Lipemic interference index of Serum or Plasma

617

1.51

3.61

2.8

3.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

658

5701

1.17

3.53

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1446

13212

1.12

3.53

1.5

21.79

21.57

nmol/l

0.22

1274

11200

(3000492) Spirometry study

634

5479

1.17

3.51

1.4

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

520

4421

1.19

3.50

2.4

22.12

26.28

au/ml

0.45

364

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1722

15893

1.11

3.50

1.6

1.30

1.34

mmol/l

1.64

1521

13360

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

158

2.03

3.49

1.5

1.4

72.55

71.77

0.09

153

(3036481) Cortisol [Moles/volume] in Serum or Plasma

647

5605

1.17

3.48

2.0

2.1

384.57

378.83

nmol/l

0.32

591

5121

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

153

2.03

3.39

1.5

1.4

671.81

440.01

mu/l

0.52

148

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

138

1001

1.39

3.38

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.58

3.37

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

271

2176

1.26

3.23

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

654

5706

1.16

3.23

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

304

2474

1.24

3.21

7.9

7.8

24.18

24.47

mmol/l

1.01

299

2405

(3021440) Promyelocytes/100 leukocytes in Blood

533

4578

1.18

3.20

4.2

4.1

0.12

0.10

0.19

153

1295

(3000570) Elastase.pancreatic [Mass/mass] in Stool

230

1822

1.27

3.08

1.4

271.50

287.49

ug/g

0.58

146

1012

(3024928) Oxygen saturation in Venous blood

131

959

1.37

3.07

4.7

2.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

123

894

1.38

3.01

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

192

1492

1.30

3.00

2.8

2.3

3.57

3.63

g/l

0.24

185

1405

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

204

1.82

2.98

2.0

1.9

159.54

165.77

0.10

190

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

145

1085

1.34

2.97

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

469

4017

1.18

2.94

1.4

1.3

173.04

174.51

u/ml

0.02

436

3683

(3029937) Albumin [Presence] in Urine by Test strip

1457

15754

0.90

2.92

4.0

4.3

0.00

estimate

2.12

586

5411

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.32

2.90

1.2

1.0

0.02

0.35

u/ml

0.49

(3024263) Appearance of Synovial fluid

258

1.71

2.89

1.3

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

133

987

1.35

2.88

1.1

7.33

13.53

au/ml

0.61

(4034850) Laboratory test

148

1941

0.76

2.86

9.5

9.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

404

3428

1.19

2.83

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

123

2.04

2.80

1.2

1.1

—

(3012544) pH of Venous blood

514

4454

1.17

2.80

4.1

3.4

7.43

7.38

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

121

890

1.37

2.79

1.3

1.2

4.63

3.33

u/ml

0.25

278

(3002179) Metamyelocytes/100 leukocytes in Blood

508

4403

1.17

2.76

3.8

3.9

0.70

0.68

0.05

160

1313

(3017181) Myelocytes/100 leukocytes in Blood

549

4791

1.16

2.73

4.1

4.0

0.78

0.91

0.41

173

1508

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

387

1.56

2.73

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

615

1.44

2.73

1.1

94.90

95.06

0.02

577

(3025159) Blasts/100 leukocytes in Blood

503

4364

1.16

2.71

4.2

4.1

1.42

0.45

0.51

125

1097

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

105

2.10

2.68

1.1

—

(3002032) Base excess in Venous blood by calculation

495

4297

1.16

2.65

4.1

3.4

2.13

2.07

mmol/l

0.13

422

3699

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

183

1441

1.28

2.63

1.5

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

2.21

2.63

1.2

—

(3019060) Gas panel - Arterial blood

260

3154

0.82

2.62

5.6

4.6

—

(3051651) Icteric interference index of Serum or Plasma

321

1.59

2.59

3.0

3.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

117

868

1.35

2.58

1.3

1.2

3.44

4.01

u/ml

0.29

342

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

100

724

1.39

2.56

1.2

58.95

60.20

u/l

0.11

650

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.06

2.56

1.1

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

172

1350

1.28

2.55

1.5

1.6

8950.63

10531.62

e6/l

0.32

118

967

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

128

965

1.33

2.54

1.3

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

276

1.63

2.54

1.7

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

133

1737

0.76

2.53

4.9

3.8

1.46

1.33

mmol/l

0.53

126

1708

(3013512) EKG study

1745

16348

1.09

2.51

3.5

3.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

278

1.62

2.48

1.7

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

468

4072

1.16

2.45

1.8

1.7

—

(3021901) Oxygen saturation in Capillary blood

107

790

1.36

2.45

2.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

112

834

1.35

2.43

3.5

3.1

1.66

1.39

0.26

102

754

(3038177) Helicobacter pylori Ab [Presence] in Serum

140

1077

1.31

2.43

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.13

2.43

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

361

0.50

2.37

1.5

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

108

804

1.35

2.36

1.9

2.0

8.67

5.80

umol/l

0.62

585

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

114

857

1.34

2.34

1.1

123.52

121.28

0.32

102

763

(1001926) Buprenorphine [Presence] in Urine by Screen method

163

1296

1.26

2.22

1.3

2.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

232

1918

1.22

2.22

1.5

1.8

0.24

0.23

g/l

0.48

213

1809

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

5.56

2.21

1.0

3.60

2.33

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.69

2.20

1.5

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

489

4309

1.15

2.18

4.2

3.4

5.88

5.84

kpa

0.47

470

4190

(3023410) Appearance of Cerebral spinal fluid

576

1.39

2.17

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

937

8584

1.11

2.17

2.4

2.3

13.32

12.95

umol/l

0.84

879

7924

(3005719) IgG [Mass/volume] in Serum or Plasma

487

4292

1.15

2.17

2.8

10.09

10.30

g/l

0.58

435

3950

(3006462) Nitrate [Presence] in Urine

297

1.55

2.15

3.4

3.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

108

1.95

2.14

1.4

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

202

1653

1.23

2.14

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

647

1.36

2.12

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

383

3324

1.16

2.12

1.3

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

171

1378

1.25

2.10

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

731

6623

1.12

2.09

4.8

4.7

1.06

1.04

mmol/l

0.87

671

6099

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

589

1.38

2.09

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

5.00

2.07

2.2

1.9

—

(3019150) Specific gravity of Urine by Refractometry

1187

12756

0.92

2.05

3.9

4.4

1.01

1.02

kg/l

0.50

258

1944

(3045424) Erythrocytes [Presence] in Urine

131

1031

1.28

1.98

1.5

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

235

1971

1.20

1.97

1.5

1.8

1.19

g/l

0.00

220

1862

(3012516) Albumin [Mass/volume] in Urine

1445

15377

0.92

1.97

3.2

3.1

316.81

474.99

mg/l

0.72

889

8716

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

528

1.39

1.96

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

528

1.39

1.96

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

198

1635

1.22

1.95

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

455

4024

1.14

1.95

2.2

2.3

3.72

5.99

ug/l

6.58

385

3417

(3047007) Chlamydophila sp Ab [Presence] in Serum

115

893

1.29

1.93

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

530

1.38

1.92

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

186

1530

1.22

1.91

1.2

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

447

1.41

1.90

2.1

2.2

1.91

2.35

u/field

0.28

186

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5418

53286

1.08

1.89

5.4

38.85

39.06

mmol/mol

1.11

5124

49189

(3004789) Transferrin [Mass/volume] in Serum or Plasma

852

7833

1.10

1.86

2.3

2.40

g/l

0.00

799

7177

(3012441) Differential panel - Pleural fluid

383

1.44

1.84

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1071

9962

1.09

1.81

1.8

—

(3000012) Reticulocyte production index

669

0.69

1.81

2.1

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

690

6287

1.11

1.80

2.2

2.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.05

1.80

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

505

1.37

1.76

3.5

3.0

52.89

55.86

0.46

443

(3025941) Bacteria identified in Stool by Culture

400

3536

1.14

1.75

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

216

1.58

1.75

1.4

2.8

—

(40768806) Pleura Pathology biopsy report

404

1.41

1.75

1.4

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

262

3047

0.85

1.75

8.2

6.7

24.94

24.78

mmol/l

0.29

248

2898

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

640

7027

0.90

1.75

1.8

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

447

1.39

1.73

3.4

3.6

—

(3014051) Protein [Presence] in Urine by Test strip

199

1667

1.20

1.73

2.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.67

1.72

1.6

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

791

7276

1.10

1.72

2.4

22.39

21.71

0.72

694

6139

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

135

1088

1.25

1.71

1.5

1.4

0.25

0.42

nmol/l

4.26

821

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.85

1.71

1.0

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

252

2159

1.17

1.70

1.5

1.6

1.46

1.59

g/l

1.45

218

1825

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.29

1.70

2.4

1.6

54.09

42.92

umol/l

0.25

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1514

14317

1.07

1.68

2.3

2.74

2.94

mg/l

2.16

1309

12262

(43055514) Macroprolactin [Presence] in Serum or Plasma

126

1.75

1.67

1.3

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

174

2085

0.83

1.66

4.2

3.6

42.71

48.06

2.16

174

2060

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

528

1.35

1.66

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

528

1.35

1.66

1.2

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

899

0.74

1.66

1.4

1.5

—

(3011288) Drugs identified in Urine by Screen method

140

1138

1.24

1.66

1.5

2.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

309

1.46

1.65

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

529

1.35

1.64

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

110

871

1.27

1.64

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.25

1.63

15.1

11.8

4.32

4.90

mmol/l

0.58

(4146454) Self-monitoring of blood glucose

547

0.67

1.62

2.7

2.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

128

1.72

1.60

1.2

189.12

100.74

nmol/l

1.19

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

230

1.52

1.59

1.1

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

206

1.56

1.59

2.0

2.2

52.42

51.06

umol/l

0.09

172

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.69

1.58

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

325

2858

1.14

1.57

1.8

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

610

5568

1.10

1.57

2.1

1.9

—

(3003694) ABO and Rh group [Type] in Blood

1662

15806

1.07

1.57

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1485

14071

1.07

1.56

2.2

2.3

5340.89

3782.38

umol/l

0.74

1319

12221

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

359

3180

1.14

1.56

1.7

1.6

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

586

1.32

1.56

2.4

2.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1531

16124

0.93

1.56

3.7

3.6

8.74

8.25

mg/mmol

0.12

913

9167

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

137

1.68

1.54

2.2

1.8

15.89

44.31

u/l

1.27

126

(3020779) Urea [Moles/volume] in Serum or Plasma

438

3931

1.12

1.54

6.0

6.4

8.55

8.84

mmol/l

0.40

415

3752

(3028026) IgM [Mass/volume] in Serum or Plasma

377

3355

1.13

1.53

1.8

1.37

1.34

g/l

0.05

339

3057

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

137

1124

1.22

1.51

2.7

3.3

275.09

634.22

u/ml

0.55

119

1011

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5783

57149

1.08

1.47

4.5

4.4

5.78

5.80

mmol/l

0.60

5427

52204

(3022689) Creatine [Moles/volume] in Urine

155

1.62

1.46

1.4

1.5

—

(4212803) Bone marrow aspirate examination

2.22

1.46

1.0

—

(3027944) Amphetamines [Presence] in Urine

197

1679

1.18

1.46

1.4

1.9

—

(3027008) Opiates [Presence] in Urine

199

1700

1.18

1.44

1.4

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

1.79

1.42

1.1

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

413

1.36

1.42

1.2

1.5

40.40

20.46

u/ml

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.25

1.40

1.0

1.1

7.67

14.82

u/l

—

(3028300) Cannabinoids [Presence] in Urine

199

1705

1.17

1.40

1.4

1.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

372

1.37

1.39

1.9

2.0

19.00

17.87

nmol/l

0.37

348

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

120

982

1.23

1.38

1.7

1.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

187

1596

1.18

1.38

1.2

—

(3021788) Differential panel - Synovial fluid

127

1047

1.22

1.37

1.5

—

(3011648) Oxygen content in Venous blood

382

1.36

1.8

2.1

12.12

10.79

1.39

382

(3047352) Trisomy 18 risk [Likelihood] in Fetus

152

1277

1.19

1.35

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

143

1.61

1.34

1.5

1.9

9450.92

29727.85

e6/l

0.62

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

1.33

0.0

1.0

—

4.93

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

157

1325

1.19

1.33

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

650

0.74

1.32

1.6

1.7

91.44

90.02

1.66

642

(3016650) Hepatitis A virus Ab [Presence] in Serum

108

880

1.23

1.31

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

437

1.33

1.30

1.7

1.5

5.69

6.58

u/l

0.21

356

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.09

1.30

1.1

1.0

8.72

8.12

mmol/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

157

1329

1.19

1.29

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

139

1164

1.20

1.29

1.2

1.3

17.26

15.71

u/l

0.46

121

955

(3000764) Benzodiazepines [Presence] in Urine

196

1691

1.16

1.28

1.4

1.9

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

185

1589

1.17

1.28

1.3

19.21

45.79

u/ml

3.70

182

(3016879) Cocaine [Presence] in Urine

181

1552

1.17

1.28

1.4

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

124

1028

1.21

1.28

1.3

—

(3019225) pH of Specimen

637

5894

1.09

1.27

4.2

3.9

—

(3000034) Microalbumin [Mass/volume] in Urine

483

1.31

1.26

3.0

2.8

59.42

36.53

mg/l

0.25

327

(3015171) Extractable nuclear Ab [Units/volume] in Serum

317

2831

1.13

1.26

1.3

0.42

1.24

u/ml

2.16

251

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

227

1.46

1.26

1.2

0.33

0.31

g/l

1.33

178

(3009261) Glucose [Presence] in Urine by Test strip

3085

30021

1.05

1.26

3.8

3.9

0.00

estimate

1.80

572

5436

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

112

922

1.22

1.25

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

150

1272

1.18

1.22

1.4

—

(3047181) Lactate [Moles/volume] in Blood

183

1578

1.16

1.22

5.2

5.5

1.36

1.25

mmol/l

0.76

167

1397

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.16

1.21

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

221

1.45

1.20

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

221

1.45

1.20

1.3

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

101

1228

0.82

1.20

3.0

3.4

—

(3047189) Immunofixation for 24 hour Urine

226

0.57

1.20

1.3

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

409

1.32

1.19

1.4

69078.46

57442.13

e6/l

0.10

235

(3002619) Bacteria identified in Specimen by Culture

125

1.60

1.17

1.1

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

224

0.58

1.16

3.1

3.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.00

1.16

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

299

1.37

1.16

2.3

1.9

2.50

2.63

u/field

0.04

207

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

153

1781

0.86

1.13

3.3

3.4

25.23

25.09

mmol/l

0.29

141

1630

(3036048) Francisella tularensis Ab [Titer] in Serum

114

0.44

1.12

1.0

1.1

—

222.86

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1064

0.82

1.12

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

258

0.62

1.12

1.7

2.6

49.17

44.45

0.84

162

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

515

5574

0.92

1.11

3.0

3.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.96

1.11

7.5

4.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1197

12566

0.94

1.11

1.6

23529863.22

31036604.67

pmol/l

0.21

1037

10346

(3016018) Differential panel - Cerebral spinal fluid

628

1.24

1.10

1.2

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

3053

29772

1.05

1.10

5.3

5.2

0.00

estimate

1.60

583

5413

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2188

22598

0.95

1.10

3.9

4.1

—

(3009871) Measles virus Ab [Titer] in Serum

218

1.42

1.08

1.9

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

473

4356

1.09

1.08

2.2

2.5

66.61

66.55

g/l

0.07

429

3928

(3033923) Metanephrine [Moles/time] in 24 hour Urine

128

1.56

1.08

1.1

0.62

0.63

umol/24h

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

177

1.47

1.07

1.8

2.5

—

(3044941) Cell count panel - Synovial fluid

104

866

1.20

1.07

1.5

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

232

2059

1.13

1.06

1.3

43.12

42.40

u/ml

0.01

143

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

103

858

1.20

1.06

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

506

1.27

1.06

1.4

34.05

32.97

g/l

0.32

462

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.92

1.06

1.5

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

114

959

1.19

1.06

1.7

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

186

1.45

1.05

1.8

1.6

0.41

0.40

ug/l

0.07

120

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

111

933

1.19

1.04

1.3

0.36

0.29

nmol/l

—

(3009343) pH of Capillary blood

310

2803

1.11

1.04

3.0

3.2

7.42

0.13

386

(3010838) Calcium [Moles/time] in 24 hour Urine

151

1303

1.16

1.04

1.7

1.9

4.71

5.13

mmol/24h

1.23

134

1154

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

223

1978

1.13

1.04

4.9

4.7

1.73

1.61

0.61

210

1855

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

655

0.78

1.02

1.5

—

(3015736) pH of Urine

2319

23884

0.96

1.02

3.4

3.5

5.92

0.01

209

1826

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

780

1.21

1.02

1.3

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

105

881

1.19

1.01

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

213

1.41

1.01

1.2

111.92

114.46

0.16

185

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

281

2533

1.11

1.00

9.0

8.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

123

1439

0.85

1.00

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.65

1.00

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.65

1.00

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.65

1.00

1.1

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

709

1.22

1.00

4.5

4.6

87.29

110.31

u/ml

0.19

208

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

139

1.51

0.99

1.2

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

925

8770

1.06

0.99

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

312

2836

1.10

0.96

3.0

3.3

5.18

5.19

kpa

0.03

301

2691

(3020717) Zinc [Moles/volume] in Serum or Plasma

337

1.31

0.95

1.3

1.5

31.19

25.89

umol/l

0.49

321

(3029075) Extractable nuclear Ab panel - Serum

191

1.42

0.94

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

106

898

1.18

0.94

1.2

1.1

1.55

1.33

u/ml

0.11

423

(3021879) Hepatitis B virus core Ab [Presence] in Serum

441

4081

1.09

0.93

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

190

1684

1.13

0.92

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

110

937

1.18

0.92

1.3

130.63

116.95

u/ml

0.26

216

(3003740) Influenza virus B Ag [Presence] in Specimen

104

882

1.18

0.91

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

546

5102

1.08

0.91

1.2

152.71

158.50

iu/ml

0.09

200

2010

(1002224) Polysomnography panel

243

2188

1.11

0.91

1.0

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

160

1.44

0.88

4.0

3.6

53.61

51.68

0.16

153

(3023199) Leukocytes [#/volume] in Pleural fluid

466

1.25

0.88

1.4

2431.85

2342.43

e6/l

0.03

342

(3035637) Corticotropin [Mass/volume] in Plasma

702

1.20

0.88

1.8

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

111

1.53

0.87

2.9

1.9

12.96

16.29

umol/l

0.73

111

(3017143) Hepatitis C virus Ab [Presence] in Serum

668

6299

1.07

0.87

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

440

1.25

0.87

1.1

8.60

9.27

iu/ml

0.10

110

(3035933) Granulocytes/100 leukocytes in Blood

161

1.43

0.86

1.3

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

128

1112

1.15

0.85

1.1

0.90

1.94

u/ml

2.00

524

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

760

1.19

0.85

1.3

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.78

0.84

1.8

2.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

208

1868

1.12

0.84

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

179

1.40

0.83

1.1

0.26

2.70

u/ml

1.37

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

129

1.47

0.83

1.2

1.1

120.21

113.07

0.67

123

(3005988) Vibrio sp identified in Specimen by Organism specific culture

762

1.18

0.83

1.3

1.4

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.88

0.81

1.8

1.6

0.77

0.84

umol/l

—

(3027801) Oxygen [Partial pressure] in Arterial blood

589

5546

1.07

0.81

7.0

6.3

12.87

12.78

kpa

0.13

564

5293

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

206

1.36

0.81

4.3

4.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

589

5548

1.07

0.81

7.1

6.3

5.15

5.09

kpa

0.76

564

5299

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

765

1.18

0.80

1.3

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

164

1.40

0.79

1.5

2.1

8314.62

4116.11

e6/l

0.20

106

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

437

1.24

0.79

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.7

—

296.96

—

(3000330) Specific gravity of Urine by Test strip

315

2901

1.09

0.78

3.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

141

1243

1.14

0.78

2.5

2.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

767

1.18

0.78

1.3

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

151

0.60

0.78

1.0

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.52

0.78

1.8

3.0

19.40

1679.40

u/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

611

5773

1.06

0.77

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

617

0.81

0.77

2.4

2.0

33.46

32.21

1.85

611

(44813793) Dust mix specific IgE antibody measurement

484

0.78

0.77

1.1

—

(3036180) Methadone [Presence] in Urine

191

1.36

0.76

1.2

3.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.77

0.76

1.0

1.1

23.50

25.76

u/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

760

1.17

0.76

1.3

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1096

10531

1.05

0.75

1.7

1058.85

1196.99

nmol/l

6.13

823

7898

(3010421) pH of Blood

116

1326

0.87

0.75

3.0

3.2

7.43

7.42

0.57

107

1219

(3043410) Blood group antigens tested for on Red Blood Cells

149

1.41

0.75

1.8

1.4

—

(3033799) Differential panel - Peritoneal fluid

149

1.41

0.75

1.4

1.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.70

0.75

2.2

2.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

735

0.83

0.75

2.0

2.1

20.65

27.03

mg/l

0.67

202

(4200892) Spirometry reversibility

407

4360

0.93

0.75

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

165

1475

1.12

0.74

4.7

3.0

0.36

0.38

u/ml

0.39

103

864

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

232

0.69

0.74

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.08

0.74

1.0

1.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.08

0.74

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

1.67

0.74

1.0

1.1

—

(3019977) pH of Arterial blood

262

1.30

0.74

2.1

3.2

7.42

0.20

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

278

0.72

0.74

1.1

1491.45

1541.14

miu/ml

0.07

278

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5950

59104

1.05

0.74

4.9

4.8

2.86

2.87

mmol/l

0.37

5594

54418

(3022493) Free Hemoglobin [Mass/volume] in Plasma

184

1.36

0.73

1.0

4.9

121.43

57.24

mg/l

0.45

120

(3014891) Appearance of Pleural fluid

1.64

0.73

1.4

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

150

1.40

0.73

1.2

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

451

1.22

0.73

1.3

1.2

—

148.82

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

451

1.22

0.73

1.3

1.2

86.00

182.41

titre

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.00

0.72

1.0

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

207

0.68

0.72

2.4

3.0

—

61.50

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

202

1.34

0.72

1.2

1.1

118.26

115.55

0.11

177

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

398

1.23

0.71

1.4

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

256

1.29

0.70

1.2

134.85

134.66

mmol/24h

0.00

256

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

207

1883

1.10

0.69

1.3

4.10

6.81

u/ml

1.00

326

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

695

0.83

0.69

1.3

1.2

19.95

25.10

u/l

0.51

597

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

199

1808

1.10

0.68

1.5

1.6

61.62

0.25

iu/ml

0.50

375

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.64

0.68

1.2

1.1

1.50

1.58

umol/24h

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

240

1.29

0.67

1.2

1.1

126.78

148.80

iu/ml

0.40

234

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

178

1611

1.11

0.67

2.0

2.1

9.83

11.32

mg/l

1.67

164

1493

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.63

0.66

1.1

1.2

—

(3044007) Cell count panel - Peritoneal fluid

136

1.40

0.66

1.4

2.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

306

0.75

0.66

1.2

1.3

201.61

270.18

u/l

0.38

279

(3012501) Base excess in Blood by calculation

1120

0.87

0.66

3.2

3.3

2.71

2.60

mmol/l

0.10

781

(1761868) Lipid panel - Serum or Plasma

2006

20552

0.97

0.66

2.5

2.7

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.51

0.66

1.2

1.1

—

(3011985) Renin [Units/volume] in Plasma

809

1.15

0.66

1.7

1.4

26.97

52.93

mu/l

2.76

718

(3009508) Creatinine [Moles/volume] in Urine

1605

16509

0.96

0.66

3.1

3.0

6.37

6.51

mmol/l

0.71

1394

13878

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

204

1862

1.10

0.65

1.3

9.25

4.51

u/ml

0.36

206

(3016038) Potassium [Moles/volume] in Urine

385

1.22

0.65

1.1

1.2

29.82

34.25

mmol/l

0.81

324

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

277

1.26

0.65

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

102

895

1.14

0.64

1.1

1.46

3.86

u/ml

2.89

415

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

101

1149

0.88

0.64

1.7

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

380

3563

1.07

0.64

3.7

2.9

4.69

4.53

kpa

0.62

363

3450

(3014271) Vancomycin [Susceptibility]

247

0.73

0.64

2.7

3.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

127

0.63

1.5

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

341

1.23

0.63

1.2

1.0

1.01

1.08

u/l

0.66

152

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

328

3061

1.08

0.63

1.6

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

607

5778

1.06

0.63

1.6

1.43

1.36

0.64

531

5062

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

460

1.20

0.62

1.5

1.3

2.28

1.58

u/ml

0.24

247

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

381

0.79

0.62

1.6

1.5

—

(3017732) Neutrophils [#/volume] in Blood

455

4296

1.06

0.62

3.2

2.7

3.89

4.55

e9/l

2.91

387

3485

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.52

0.62

1.3

1.2

217.77

429.27

ug/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

424

1.20

0.62

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

507

1.19

0.61

2.1

2.5

0.74

1.04

g/24h

0.62

231

(3028707) Methadone [Presence] in Urine by Screen method

758

1.15

0.61

1.3

2.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.60

0.0

2.0

—

(3013862) HLA-DP [Type]

0.00

0.60

0.0

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

311

2904

1.07

0.60

1.5

—

(3017569) Oxygen content in Arterial blood

218

1.29

0.60

1.9

2.4

—

(3003181) Sodium [Moles/volume] in Urine

117

1043

1.12

0.59

1.3

1.4

54.70

62.87

mmol/l

1.73

829

(3035350) Ketones [Presence] in Urine by Test strip

3010

29609

1.03

0.59

3.8

3.9

0.00

estimate

0.24

629

5782

(3010144) Erythrocytes [#/volume] in Synovial fluid

508

0.83

0.58

1.3

1.4

87833.15

122203.73

e6/l

0.17

339

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

866

1.13

0.58

1.4

1.3

7.16

7.22

mmol/l

0.06

762

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.71

0.57

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

229

1.27

0.56

1.8

2.0

—

(40767503) Oxygen content in Capillary blood by calculation

1041

0.88

0.56

2.8

2.4

16.73

16.10

0.98

516

(3007930) Methemoglobin/Hemoglobin.total in Blood

213

1966

1.09

0.56

5.1

4.8

0.87

0.91

1.16

198

1848

(3004588) Protein electrophoresis panel - Serum or Plasma

386

3642

1.06

0.56

2.1

2.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.58

0.56

1.6

2.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.57

0.56

2.6

1.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.46

0.56

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

106

944

1.12

0.56

1.5

0.54

0.63

g/l

0.63

701

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

194

1.29

0.55

1.2

1.1

94.00

93.89

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

537

0.84

0.55

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

537

0.84

0.55

1.4

—

(40765096) Chromosome analysis panel by Banding

126

0.63

0.54

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

358

1.20

0.53

1.0

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

441

1.18

0.53

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

145

1592

0.91

0.53

2.7

3.2

1.48

1.42

ratio

0.14

134

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.45

0.53

1.0

—

7.15

—

(3003396) Base excess in Arterial blood by calculation

579

5539

1.05

0.52

7.1

6.3

0.79

1.24

mmol/l

2.14

487

4470

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

170

1560

1.09

0.52

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

150

1642

0.91

0.52

2.6

3.3

34.03

81.24

mg/l

0.76

125

1336

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

169

1553

1.09

0.51

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

347

0.81

0.50

2.1

2.5

971.14

762.81

e6/l

1.01

332

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

370

1.19

0.50

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.41

0.50

1.8

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

169

1556

1.09

0.49

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

190

0.74

0.49

1.1

1.2

—

20.90

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

497

0.84

0.48

1.5

31.73

35.81

0.34

279

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

647

0.86

0.48

1.9

1.6

—

(3020650) Glucose [Presence] in Urine

145

1.31

0.48

1.6

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

107

0.65

0.48

1.4

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

108

0.65

0.48

1.7

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

268

2515

1.07

0.48

1.9

2.1

40.24

39.71

u/l

0.15

243

2242

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

169

1558

1.09

0.48

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

268

2852

0.94

0.47

4.3

3.0

126.90

127.06

g/l

0.04

262

2785

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

151

1642

0.92

0.47

2.6

3.3

25.69

38.40

mg/l

2.02

128

1332

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

550

1.15

0.47

1.4

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

327

1.19

0.47

1.3

1.2

—

(3022475) Manganese [Moles/volume] in Blood

1.46

0.46

1.1

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

323

3055

1.06

0.46

1.1

328.88

188.23

titre

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

676

0.87

0.46

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

288

0.80

0.46

1.6

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

165

0.73

0.46

3.1

2.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

291

1.20

0.46

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2090

20523

1.03

0.46

3.1

3.3

61.11

61.55

ng/l

0.00

1213

12813

(3023520) Reticulocytes [#/volume] in Blood

427

4073

1.05

0.45

2.1

2.5

68.24

71.54

e9/l

1.05

307

3027

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

255

1.22

0.45

1.1

—

(3042517) Benzodiazepines panel - Urine

1.40

0.45

1.0

2.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

105

951

1.11

0.44

1.3

58.72

59.18

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

657

1.13

0.44

1.3

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.45

0.44

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

167

1800

0.93

0.43

1.1

1.21

7.54

u/ml

3.29

226

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

358

1.17

0.43

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

321

1.18

0.43

1.1

1.0

0.09

0.35

u/ml

2.90

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

176

1636

1.08

0.43

1.8

2.2

263.69

505.41

ug/l

0.87

160

1506

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

461

1.15

0.43

2.0

2.9

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

104

1.35

0.43

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

104

1.35

0.43

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

697

1.12

0.42

1.1

1.52

1.51

g/l

0.06

622

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

110

1206

0.91

0.42

1.2

1.4

33.89

32.73

u/l

0.13

994

(3023511) Choriogonadotropin [Units/volume] in Urine

141

1300

1.09

0.42

1.3

—

(4062490) Immunoglobulin typing, IgG

603

1.13

0.42

1.6

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

198

1851

1.07

0.42

1.6

160.00

299.63

titre

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

870

0.90

0.42

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

285

2698

1.06

0.41

3.0

3.2

2.31

1.97

mmol/l

0.96

209

2062

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

813

1.11

0.41

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

813

1.11

0.41

1.6

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.52

0.41

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.52

0.41

1.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

5.3

—

1.70

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

626

0.88

0.41

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

482

1.14

0.41

6.2

6.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

314

1.18

0.41

1.5

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

186

1.24

0.40

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.33

0.40

1.1

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

587

1.13

0.40

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

793

0.89

0.40

1.3

1.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.43

0.39

1.4

1.5

0.10

0.46

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

297

1.18

0.39

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.41

0.39

1.1

—

(40760410) HLA-B [Type] by High resolution

0.00

0.39

0.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.39

0.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.39

0.0

1.1

—

(40763590) HLA-DQ beta [Type]

0.00

0.39

0.0

1.1

—

(3034426) Prothrombin time (PT)

196

1.23

0.39

1.3

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

151

1.26

0.38

1.3

1.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.39

0.38

13.2

4.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.39

0.38

1.0

1.7

19.08

15.22

pmol/l

—

(3013466) aPTT in Blood by Coagulation assay

1.39

0.38

1.0

34.64

35.76

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

280

0.82

0.38

10.1

16.7

1048.04

4924.01

nmol/l

0.60

271

(3028433) Virus identified in Specimen by Culture

197

1.22

0.37

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

657

1.11

0.37

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

648

1.11

0.37

1.1

1.0

0.33

u/ml

0.00

160

(3045788) Cell count panel - Pleural fluid

374

1.15

0.36

1.5

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

290

1.17

0.36

1.1

—

(3015183) Erythrocyte sedimentation rate

300

0.83

0.36

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

201

1894

1.06

0.36

1.7

1.9

3.33

8.77

iu/l

0.67

714

(3023419) Bacteria identified in Sputum by Culture

735

1.10

0.36

2.4

2.6

—

(40768441) Liver Pathology biopsy report

450

1.13

0.36

1.1

1.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

671

0.89

0.36

1.1

—

1.54

—

(3036071) Salmonella sp Ab [Titer] in Serum

171

1.23

0.35

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

319

1.16

0.35

10.5

12.3

0.64

0.63

mmol/l

0.08

292

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5830

58060

1.03

0.35

4.4

4.3

4.89

4.88

mmol/l

0.19

5479

53685

(40761539) Cells [Type] in Urine sediment by Light microscopy

126

1.27

0.35

1.1

—

(3001729) Color of Synovial fluid

1.40

0.35

1.3

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

603

1.11

0.35

1.6

1.4

2.46

2.83

g/l

1.16

414

(3006184) Hemoglobin [Mass/volume] in Capillary blood

125

1160

1.08

0.34

2.3

2.2

132.53

127.14

g/l

2.22

816

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.37

0.34

1.2

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

361

3463

1.04

0.34

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

604

1.11

0.34

1.6

1.4

5.95

6.60

g/l

1.08

415

(3024139) IgG subclass 3 [Mass/volume] in Serum

604

1.11

0.34

1.6

1.4

0.33

0.40

g/l

1.31

415

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.34

0.34

1.1

1.0

—

(3004451) EKG impression Narrative

232

0.82

0.33

1.5

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

188

0.80

0.33

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

173

1.21

0.32

1.2

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

1.28

0.32

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

208

0.82

0.31

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

202

1.19

0.31

1.0

98.33

90.12

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

0.71

0.30

1.0

1.2

—

0.53

—

(1761482) Bacteria [#/volume] in Urine by Culture

142

1333

1.07

0.30

4.6

4.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

272

0.85

0.30

9.0

11.4

631.52

860.36

nmol/l

1.93

261

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

129

1.24

0.30

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

160

1510

1.06

0.29

2.6

2.7

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.25

0.29

1.7

3.2

—

32.71

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

439

1.12

0.29

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

439

1.12

0.29

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

439

1.12

0.29

1.7

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

153

1443

1.06

0.29

1.4

—

(3037756) Immunofixation for Serum or Plasma

1034

0.93

0.29

1.6

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

133

1249

1.07

0.29

1.3

1.4

17.29

30.29

e6/l

0.39

106

950

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

108

0.74

0.29

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.23

0.29

1.0

1.1

—

(21494434) Karyotype in Bone marrow

392

1.12

0.29

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

108

1007

1.07

0.28

1.1

3.14

4.54

u/ml

0.51

484

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

133

1250

1.07

0.28

1.3

1.4

336.82

4703.31

e6/l

0.84

108

1009

(21494755) Public health laboratory ask at order entry panel

520

5353

0.97

0.28

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

846

0.92

0.28

1.7

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

223

1.17

0.28

2.1

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

223

1.17

0.28

2.1

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

450

1.11

0.28

1.2

1.3

2.51

1.29

nmol/l

0.59

371

(3008401) Mugwort IgE Ab [Units/volume] in Serum

103

960

1.07

0.28

1.1

0.93

u/ml

0.00

378

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.29

0.28

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

149

1.21

0.27

1.9

1.8

380.91

164.94

e6/l

0.50

(3016502) Oxygen saturation in Arterial blood

498

4836

1.03

0.27

7.3

6.7

95.18

95.88

1.15

475

4656

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

741

0.92

0.27

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.23

0.27

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.23

0.27

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

531

0.90

0.26

1.3

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

100

934

1.07

0.26

2.8

1.9

0.75

0.79

nmol/l

0.27

783

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

587

1.09

0.26

1.1

—

39.84

—

(3008898) HLA-B27 [Presence]

234

2243

1.04

0.26

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

707

0.92

0.26

1.5

1.6

45.93

55.03

1.09

428

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

561

0.91

0.25

1.6

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

396

1.11

0.25

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

110

1033

1.07

0.25

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

508

0.90

0.25

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

368

1.11

0.25

1.4

1.3

1.71

1.63

g/l

0.78

368

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

226

1.15

0.24

2.1

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

350

0.89

0.24

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

126

0.79

0.24

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.74

0.24

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

832

1.07

0.24

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

265

1.13

0.23

1.2

1.5

14.51

15.22

pmol/l

0.38

215

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

422

0.90

0.23

1.3

—

(3042631) Mycobacterium sp identified in Specimen

649

1.08

0.23

2.4

2.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

361

1.11

0.22

1.2

1.5

5.38

5.79

u/l

0.29

305

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

150

1429

1.05

0.22

1.2

1.3

445.26

509.49

mg/l

1.65

144

1362

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

587

0.92

0.22

2.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

545

0.92

0.22

4.3

3.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

135

0.81

0.22

2.4

1.5

16.35

17.35

umol/l

0.30

119

(3011436) Histone Ab [Units/volume] in Serum

135

0.81

0.22

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

124

0.81

0.21

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.19

0.21

1.2

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.19

0.21

1.0

1.2

—

(40763791) Oxygen content in Venous blood by calculation

0.00

0.21

0.0

4.7

—

10.64

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.21

0.0

2.4

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.3

—

2768.65

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

207

2151

0.96

0.21

1.6

1.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

7.21

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

730

1.07

0.21

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

537

1.08

0.20

1.9

5.1

9.64

7.26

mmol/l

0.47

437

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

418

0.91

0.20

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

412

1.09

0.20

1.1

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.2

—

47.11

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.20

0.0

3.8

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.20

0.0

4.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

250

0.88

0.20

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

250

0.88

0.20

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1409

14260

0.98

0.19

3.4

3.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.19

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

333

0.90

0.19

1.4

1.5

1.02

1.15

promille

0.21

247

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

241

1.12

0.19

1.7

2.2

82.44

148.31

umol/l

1.38

130

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5779

57644

1.02

0.18

4.4

4.2

1.62

1.59

mmol/l

4.96

5446

53065

(3014599) Egg white IgE Ab [Units/volume] in Serum

366

1.09

0.18

1.1

1.0

0.45

0.93

u/ml

0.91

(44816559) Phosphatidylethanol [Mass/volume] in Blood

930

0.95

0.18

1.1

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

368

3772

0.97

0.18

1.9

1.7

—

(3010503) CD19 cells [#/volume] in Blood

342

0.91

0.18

2.3

0.12

0.46

e9/l

0.96

332

(3009445) Proteinase 3 Ab [Units/volume] in Serum

243

2356

1.03

0.18

1.5

1.6

7.76

13.19

u/ml

—

(21491868) Cryoglobulin [Mass/volume] in Serum

223

1.12

0.18

1.0

1.1

—

0.28

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.19

0.18

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

528

0.93

0.18

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

746

1.06

0.17

1.1

5.59

3.42

u/ml

0.36

283

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

406

1.08

0.17

1.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

233

2259

1.03

0.17

1.4

1.5

148.09

161.61

pmol/l

0.15

228

2202

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

341

0.91

0.17

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

130

1246

1.04

0.17

2.8

1.44

1.47

mg/l

0.18

121

1144

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.74

0.17

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

517

5072

1.02

0.16

1.7

1.6

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.18

0.16

1.8

1.57

1.52

mg/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

866

1.05

0.16

1.3

1.4

2.79

3.69

ug/l

1.24

731

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.14

0.16

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.79

0.15

1.8

2.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.78

0.15

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

149

1.14

0.15

1.9

3.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

149

1.14

0.15

1.9

3.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

448

1.07

0.15

2.1

2.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

170

1645

1.03

0.15

1.2

95.00

145.40

titre

—

137

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

182

0.88

0.15

1.7

7.84

8.51

ug/l

0.38

182

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.11

0.15

5.6

7.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

234

0.90

0.15

1.4

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

859

1.05

0.15

2.8

2.6

30.98

33.19

umol/l

0.55

779

(1616796) Gas panel - Central venous blood

104

1085

0.96

0.15

3.6

3.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

102

977

1.04

0.15

1.3

1.2

248.87

283.50

u/ml

0.74

619

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

119

1144

1.04

0.14

1.3

1.2

—

(40761511) CBC panel - Blood by Automated count

6135

61250

1.02

0.14

13.0

12.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.81

0.14

1.1

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

115

1196

0.96

0.14

3.5

19.23

24.12

mg/l

0.99

732

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

223

0.90

0.14

1.1

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

223

0.90

0.14

3.8

11.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

112

1.16

0.14

7.1

4.7

38.00

63.32

u/l

0.88

107

(3009466) Valproate [Moles/volume] in Serum or Plasma

684

1.05

0.14

5.2

5.1

363.67

375.44

umol/l

0.29

588

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

378

0.93

0.14

2.1

2.2

586.04

503.82

e6/l

0.34

313

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

184

1786

1.03

0.14

1.9

2.89

2.02

ug/l

0.24

161

1572

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

542

0.94

0.14

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.82

0.13

2.9

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.82

0.13

1.4

6.21

23.19

—

(3020874) Milk IgE Ab [Units/volume] in Serum

373

1.07

0.13

1.1

0.33

1.86

u/ml

0.93

117

(3036670) Protein [Mass/volume] in Synovial fluid

170

1.12

0.13

1.2

1.3

48.40

39.10

g/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

510

0.94

0.13

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

366

0.93

0.13

2.1

2.2

0.26

0.22

e9/l

0.53

312

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

113

1.15

0.13

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5557

55457

1.01

0.12

3.9

3.8

1.22

1.25

mmol/l

3.54

5202

50592

(3045142) Bone marrow Pathology biopsy report

540

1.06

0.12

1.3

—

(3037121) Protein [Mass/volume] in Urine

175

1798

0.97

0.12

2.4

2.9

0.17

0.28

g/l

2.14

609

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

137

0.88

0.12

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

547

5396

1.01

0.11

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

798

1.04

0.11

1.1

1.0

2.77

3.89

u/ml

0.22

345

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

250

0.92

0.11

1.3

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

557

0.95

0.11

2.3

2.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

377

1.06

0.10

1.6

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

352

0.94

0.10

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

115

1.13

0.10

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

505

0.95

0.10

1.6

2.1

—

(3020491) Glucose [Moles/volume] in Blood

407

1.06

0.10

1.8

7.20

6.51

mmol/l

0.73

291

(3026389) Candida sp identified in Specimen by Organism specific culture

110

1067

1.03

0.10

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

484

0.95

0.10

1.3

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

300

1.07

0.10

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

565

0.96

0.10

2.3

2.1

105.83

105.45

mmol/l

0.26

560

(3041354) Potassium [Moles/volume] in Venous blood

565

0.96

0.10

2.3

2.1

3.99

mmol/l

0.04

560

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.11

0.09

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

758

0.96

0.09

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

271

1.07

0.09

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

122

1254

0.97

0.09

1.8

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

157

1533

1.02

0.09

1.3

1.99

3.94

u/ml

0.61

111

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

176

0.91

0.09

1.2

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

174

1.09

0.09

1.6

2.4

147.00

162.70

nmol/l

0.30

151

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

469

4633

1.01

0.09

2.4

2.5

70.92

66.44

ml/min/173m2

2.06

215

1844

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

350

0.94

0.09

1.1

—

(3018572) Chloride [Moles/volume] in Blood

106

1090

0.97

0.09

7.0

6.5

104.38

105.04

mmol/l

0.71

983

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

380

1.05

0.08

1.1

6.47

10.88

nmol/l

—

(3044009) aPTT.lupus sensitive (LA screen)

1.07

0.08

1.2

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.07

0.08

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

302

1.06

0.08

1.1

1.2

—

(3039000) Anion gap in Blood

106

1089

0.97

0.08

7.0

6.5

11.14

11.03

mmol/l

0.14

982

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

214

1.08

0.08

1.3

1.5

—

562378.75

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

144

0.90

0.08

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1018

0.97

0.08

3.1

3.2

0.82

nmol/l

0.03

777

(3042733) HLA Ab [Presence] in Serum

113

0.88

0.08

4.3

5.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.81

0.08

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

627

1.04

0.08

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.78

0.08

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

389

0.95

0.08

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

250

2461

1.02

0.08

2.2

2.0

5989.13

5140.28

u/l

0.16

116

1004

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

127

1.10

0.07

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.03

0.07

3.1

2.9

0.57

0.82

u/field

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.84

0.07

1.0

1.8

—

(40758292) HTLV I+II Ab panel - Serum

0.84

0.07

1.7

1.4

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.86

0.07

1.3

2.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.80

0.07

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

128

1252

1.02

0.07

1.2

3.63

3.67

mmol/l

0.28

120

1181

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.07

0.07

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

197

1937

1.02

0.07

1.3

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

469

0.96

0.07

1.7

1.6

7.59

7.86

mmol/l

0.44

447

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

619

1.03

0.07

1.1

—

104.81

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.86

0.07

17.9

6.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

492

4967

0.99

0.07

3.5

3.4

1.25

1.24

mmol/l

4.66

454

4268

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

265

0.94

0.07

1.6

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

482

1.04

0.06

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

142

0.92

0.06

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

142

0.92

0.06

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

111

0.90

0.06

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

158

1.08

0.06

2.9

3.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

276

1.05

0.06

1.1

—

(3008295) Osmolality of Serum or Plasma

597

0.97

0.05

1.4

276.76

276.06

mosm/kgh2o

0.08

456

(3006653) Thiamine [Moles/volume] in Blood

257

1.05

0.05

1.2

1.4

139.27

128.98

nmol/l

0.92

257

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

546

0.97

0.05

1.1

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

989

0.98

0.05

3.8

4.5

588.64

410.04

iu/ml

0.17

112

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

179

1.06

0.05

2.0

3.2

44.04

92.87

ng/l

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

111

1128

0.98

0.04

1.3

1.7

—

(40768446) Kidney Pathology biopsy report

160

1.06

0.04

1.1

1.5

—

(3017704) Immunofixation for Urine

249

1.04

0.04

1.3

1.8

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

626

1.02

0.04

1.1

—

4.40

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

102

1036

0.98

0.04

2.3

2.4

97.57

52.12

ug/min

0.42

588

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

105

1034

1.02

0.04

1.3

32.00

89.52

titre

—

(21494815) CD4 cells/100 lymphocytes in Specimen

428

1.03

0.03

1.8

2.0

43.10

42.73

0.06

421

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

512

0.98

0.03

1.2

4.00

5.75

u/ml

—

(3034770) Mitochondria Ab [Titer] in Serum

168

1663

1.01

0.03

1.2

506.67

927.70

titre

—

(3011412) CD3 cells [#/volume] in Blood

542

0.98

0.03

2.0

2.1

1.43

1.23

e9/l

0.75

484

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

260

0.96

0.03

1.6

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

191

1.05

0.03

1.1

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

231

1.04

0.02

2.0

1.9

—

(3024471) HLA-A [Type]

128

0.94

0.02

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

138

0.94

0.02

1.4

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

789

1.01

0.02

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

162

1.05

0.02

1.8

2.1

1.41

1.16

ug/l

0.19

152

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

162

1.05

0.02

1.1

1.0

14.80

13.56

u/ml

—

100

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

168

0.95

0.02

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

560

0.98

0.02

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

120

1188

1.01

0.02

1.2

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

117

1180

0.99

0.01

1.6

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

759

0.99

0.01

1.2

1.1

88.10

13066.88

iu/ml

0.53

179

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

147

0.95

0.01

1.1

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

457

4557

1.00

0.01

8.1

7.0

119.48

118.82

g/l

0.34

445

4432

(3032057) Clostridioides difficile [Presence] in Stool

124

1.05

0.00

1.8

—

(3048879) Bone marrow aspiration report

134

1.04

0.00

2.1

1.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

134

1.04

0.00

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

166

0.96

0.00

1.1

—

(3035880) pH of Pleural fluid

194

1.03

0.00

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

196

0.97

0.00

1.5

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

316

0.98

0.00

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

336

0.98

0.00

1.0

266.19

365.60

ng/l

2.16

236

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

426

0.99

0.00

1.2

1.0

308.55

297.96

mg/l

0.54

375

(3024932) HLA-DR beta [Type]

123

0.98

0.00

1.0

1.2

—

(3016228) CD19 cells/100 cells in Blood

237

1.01

0.00

2.0

1.9

5.42

8.34

1.31

231

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

226

1.02

0.00

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

394

0.99

0.00

1.2

1.1

1.07

1.05

ratio

0.36

145

(3044927) Protein electrophoresis panel - Urine

516

1.01

0.00

1.1

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

155

0.97

0.00

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

155

0.97

0.00

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

155

0.97

0.00

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

155

0.97

0.00

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

285

1.02

0.00

1.6

1.4

—

(3022313) Gas panel - Capillary blood

200

2005

1.00

0.00

3.0

3.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

188

1.01

0.00

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

232

0.99

0.00

2.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

342

0.99

0.00

1.0

36.26

44.88

ng/l

0.92

238

(40757373) Influenza virus identified in Isolate

101

0.99

0.00

1.2

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

239

1.00

0.00

1.5

1.3

60.21

145.42

nmol/24h

0.72

239

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

251

1.00

0.00

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

339

1.00

0.00

1.0

761.48

719.48

ng/l

0.20

231

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

351

1.00

0.00

1.6

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

227

2271

1.00

0.00

1.5

1.7

2.84

3.88

mg/l

1.47

167

1653

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.96

0.00

5.7

7.7

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.3

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

20.43

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

220

1.00

-0.00

1.3

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

4.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.95

-0.00

1.6

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

2.36

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.4

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.2

—

(3012898) Urea [Moles/volume] in Urine

0.89

-0.00

1.0

1.4

211.60

162.62

mmol/l

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3019174) dRVVT (LA screen)

0.98

-0.00

1.0

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

2.6

—

11.80

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.00

-0.00

1.6

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

0.88

-0.00

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.96

-0.00

1.0

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

0.92

-0.00

6.8

5.5

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

298.40

—

(4281824) Cell count and differential, peritoneal fluid

100

1000

1.00

-0.00

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.98

-0.00

1.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_LUMPNASBREAST and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_LUMPNASBREAST	1.221 [1.13, 1.32]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.181

During the follow-up period (1.1.1998 — 31.12.2019), 5884 out of 38029 females with N14_LUMPNASBREAST died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_LUMPNASBREAST.

N-year risk	Females	Males
1	0.105%	No data
5	0.663%	No data
10	1.729%	No data
15	3.388%	No data
20	6.044%	No data

Relationships between endpoints

↥

Index endpoint: N14_LUMPNASBREAST – Unspecified lump in breast

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Unspecified lump in breast

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints